{"gene":"LRRC8A","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2014,"finding":"LRRC8A (SWELL1) is an essential component of the volume-regulated anion channel (VRAC). Genome-wide RNAi screens independently identified LRRC8A as required for hypotonicity-induced iodide influx and VRAC currents. Genomic disruption of LRRC8A ablated VRAC currents, and point mutations in LRRC8A cause significant changes in VRAC anion selectivity, demonstrating that LRRC8A is a pore-forming component. LRRC8A forms heteromers with other LRRC8 family members (LRRC8B-E), and the isoform combination determines VRAC inactivation kinetics. Taurine flux and regulatory volume decrease also depend on LRRC8 proteins.","method":"Genome-wide siRNA screen, CRISPR genomic disruption, patch-clamp electrophysiology, taurine flux assay, point mutagenesis","journal":"Science / Cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — two independent genome-wide screens, genomic disruption, patch-clamp, mutagenesis, replicated across two labs simultaneously","pmids":["24790029","24725410"],"is_preprint":false},{"year":2016,"finding":"LRRC8 proteins together constitute the VRAC pore. SWELL1 and up to four other LRRC8 subunits assemble into heterogeneous complexes of ~800 kDa. When reconstituted into lipid bilayers, LRRC8 complexes are sufficient to form anion channels activated by osmolality gradients. Single-channel conductance depends on LRRC8 subunit composition. Low ionic strength in the absence of an osmotic gradient activates the complexes in bilayers, demonstrating that hypotonic stress can activate VRAC through a decrease in cytoplasmic ionic strength.","method":"Reconstitution into lipid bilayers, single-channel electrophysiology, size-exclusion chromatography (~800 kDa complex), patch-clamp","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution in bilayers with functional readout, multiple orthogonal methods in single rigorous study","pmids":["26824658"],"is_preprint":false},{"year":2018,"finding":"Cryo-EM and X-ray crystallography of homomeric LRRC8A reveal a hexameric channel architecture. The transmembrane domain is structurally related to connexin proteins, wide towards the cytoplasm but constricted on the extracellular side by a selectivity filter. An excess of basic residues in the filter and throughout the pore attracts anions by electrostatic interaction. The cytoplasmic leucine-rich repeat domain follows the transmembrane pore domain.","method":"Cryo-electron microscopy, X-ray crystallography","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution structure by two independent methods (cryo-EM and X-ray crystallography) in a single study; replicated by multiple labs","pmids":["29769723"],"is_preprint":false},{"year":2018,"finding":"Cryo-EM structure of human LRRC8A shows a hexameric assembly. The transmembrane region features topology similar to gap junction channels. The LRR region (15 leucine-rich repeats) forms a long twisted arc. The channel pore is constricted on the extracellular side, where conserved polar and charged residues at the tip of the extracellular helix contribute to anion permeability. Two structural populations (compact and relaxed conformations) suggest that the LRR region undergoes rigid-body motions possibly implicated in pore opening.","method":"Single-particle cryo-electron microscopy","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure of human LRRC8A, replicates and extends Nature 2018 structure from a second independent lab","pmids":["30127360"],"is_preprint":false},{"year":2019,"finding":"Cryo-EM structures of LRRC8A in lipid nanodiscs with the inhibitor DCPIB show that DCPIB plugs the channel in the extracellular selectivity filter, sterically occluding ion conduction. Constricted and expanded structures reveal coupled dilation of cytoplasmic LRRs and the channel pore, suggesting a gating mechanism by internal stimuli. Conformational differences between detergent and lipid bilayer structures demonstrate a critical role for the membrane lipid environment in determining channel structure, including intersubunit lipid binding sites.","method":"Single-particle cryo-electron microscopy, lipid nanodisc reconstitution, inhibitor-bound structure","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution inhibitor-bound cryo-EM structure in native-like lipid bilayer environment with conformational analysis","pmids":["30775971"],"is_preprint":false},{"year":2018,"finding":"The intracellular loop (IL) connecting TM2 and TM3 of LRRC8A and the first extracellular loop (EL1) of LRRC8C/D/E are both essential for VRAC activity. A 25-amino acid sequence unique to the LRRC8A IL is sufficient to generate homomeric VRAC activity when inserted into LRRC8C or LRRC8E. LRRC8 chimeras containing partial LRRC8A IL sequences exhibit altered anion permeability, rectification, and voltage sensitivity, indicating that the LRRC8A IL contributes to pore structure and function.","method":"Chimeric channel mutagenesis, patch-clamp electrophysiology in LRRC8-/- cells","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic chimera/mutagenesis combined with functional electrophysiology, multiple constructs tested","pmids":["29853476"],"is_preprint":false},{"year":2018,"finding":"The short N-terminal stretch preceding the first LRRC8 transmembrane domain determines VRAC conductance, ion permeability, and inactivation gating. Substituted-cysteine accessibility studies reveal that the first 15 LRRC8A residues are exposed to a hydrophilic environment. Glutamate 6 (E6) controls iodide-over-chloride permeability and voltage dependence of inactivation; restoring the negative charge by MTSES reverses these effects. Cd2+-mediated blocking data suggest the N termini come close together in the multimeric complex and may line the cytoplasmic pore.","method":"Substituted-cysteine accessibility method (SCAM), site-directed mutagenesis, patch-clamp, MTSES modification","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — SCAM plus mutagenesis plus electrophysiology, multiple orthogonal approaches in one study","pmids":["29925591"],"is_preprint":false},{"year":2023,"finding":"2.8-Å cryo-EM structure of human LRRC8A shows well-resolved N-termini (NTs). The amino-terminal halves of NTs fold back into the pore and constrict the permeation path, forming a second selectivity filter working in series with the extracellular selectivity filter. The C-terminal halves of NTs interact with intracellular loops crucial for channel activation. Molecular dynamics simulations indicate that low ionic strength increases NT mobility and expands inter-helix distances, suggesting a mechanism for VRAC activation.","method":"Single-particle cryo-EM (2.8 Å), molecular dynamics simulations","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — near-atomic resolution structure with MD simulations providing mechanistic insight into activation and selectivity","pmids":["37543949"],"is_preprint":false},{"year":2022,"finding":"Cryo-EM structures of heterohexameric LRRC8A:C channels reveal a predominant assembly with A:C ratio of 2:4 (four LRRC8A and two LRRC8C subunits). Four LRRC8A subunits cluster in their preferred closed-state conformation as pairs. The two LRRC8C subunits show greater flexibility, destabilizing the tightly packed A subunits and enhancing activation. Lipids embedded in the channel pore block ion conduction in the closed state.","method":"Single-particle cryo-EM, fiducial-tagging strategy for subunit identification, functional electrophysiology","journal":"Nature structural & molecular biology / Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic cryo-EM structures of heteromeric channel in multiple conformations, replicated across two papers (28928458, 36522427)","pmids":["36928458","36522427"],"is_preprint":false},{"year":2014,"finding":"LRRC8A is an indispensable component of the swelling-activated excitatory amino acid (EAA) release pathway in rat astrocytes. siRNA knockdown of LRRC8A dramatically reduced hypo-osmotic release of D-[3H]aspartate, L-glutamate, and taurine, and completely abolished ATP-stimulated release of EAAs and taurine from non-swollen astrocytes.","method":"siRNA knockdown, radiotracer efflux assays (D-[3H]aspartate, [14C]taurine), HPLC","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with multiple radiotracer substrates and HPLC confirmation, specific to LRRC8A","pmids":["25172945"],"is_preprint":false},{"year":2014,"finding":"LRRC8A constitutively associates with the GRB2-GAB2 complex and lymphocyte-specific protein tyrosine kinase (LCK) in thymocytes. LRRC8A ligation activates AKT via the LCK-ZAP-70-GAB2-PI3K pathway, and AKT phosphorylation is markedly reduced in Lrrc8a-/- thymus. Thymic epithelial cells express an LRRC8A ligand critical for double-negative to double-positive thymocyte differentiation and survival in vitro.","method":"Co-immunoprecipitation, Lrrc8a-/- mouse phenotyping, bone marrow chimeras, flow cytometry, phospho-AKT immunoblot","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP and genetic KO with signaling readout, but single lab","pmids":["24752297"],"is_preprint":false},{"year":2017,"finding":"SWELL1/LRRC8A regulates adipocyte insulin-PI3K-AKT2-GLUT4 signaling, glucose uptake, and lipid content via interactions of the SWELL1 C-terminal leucine-rich repeat domain (LRRD) with GRB2 and Cav1. Silencing GRB2 in SWELL1 KO adipocytes rescues insulin-pAKT2 signaling. In vivo, adipose-targeted SWELL1 KO reduces adiposity and impairs systemic glycemia and insulin sensitivity.","method":"Co-immunoprecipitation (LRRD-GRB2/Cav1 interaction), adipose-specific KO mice, patch-clamp, glucose uptake assay, siRNA rescue","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, specific domain mutant, tissue-specific KO in vivo, rescue experiment, multiple orthogonal methods","pmids":["28436964"],"is_preprint":false},{"year":2020,"finding":"LRRC8A/LRRC8E-containing VRACs transport cGAMP and cyclic dinucleotides across the plasma membrane, enabling cell-to-cell transmission of the innate immune second messenger cGAMP. Chemical blockade or genetic ablation of LRRC8A results in defective interferon responses to HSV-1. Enhancing VRAC activity by hypotonic swelling, cisplatin, GTPγS, or cytokines (TNF, IL-1) increases STING-dependent IFN responses to extracellular cGAMP. Lrrc8e-/- mice exhibit impaired IFN responses and compromised immunity to HSV-1.","method":"Biochemical transport assay, electrophysiology, genetic ablation (LRRC8A KO, Lrrc8e-/- mice), IFN ELISA, viral challenge","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — electrophysiology plus biochemical transport assay plus in vivo genetic model, multiple orthogonal methods","pmids":["32277911"],"is_preprint":false},{"year":2020,"finding":"LRRC8A forms complexes with LRRC8C and/or LRRC8E to transport cGAMP and other 2'3'-cyclic dinucleotides as an importer or exporter depending on the electrochemical gradient. LRRC8D inhibits cGAMP transport. Activation of LRRC8A channels by sphingosine 1-phosphate potentiates cGAMP transport. LRRC8A channels are the key cGAMP transporters in resting primary human vasculature cells.","method":"Genome-wide CRISPR screen, cGAMP transport assay, STING reporter assay, pharmacological activation/inhibition (S1P, DCPIB)","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR screen plus mechanistic transport assays with activators/inhibitors, replicated findings from PMID:32277911","pmids":["33171122"],"is_preprint":false},{"year":2019,"finding":"Astrocytic SWELL1/LRRC8A mediates non-vesicular glutamate release through VRAC. Both cell swelling and receptor stimulation activate astrocytic VRAC, which requires SWELL1. Astrocyte-specific Swell1 KO mice exhibit impaired glutamatergic transmission (reduced presynaptic release probability and ambient glutamate), hippocampal-dependent learning/memory deficits, and attenuated neuronal excitability and brain damage after ischemic stroke.","method":"Astrocyte-specific conditional KO mice, whole-cell patch-clamp, glutamate release assay, behavioral testing, ischemia model (MCAO)","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific KO with multiple orthogonal functional readouts (electrophysiology, neurochemistry, behavior, in vivo stroke model)","pmids":["30982627"],"is_preprint":false},{"year":2018,"finding":"SWELL1 mediates a swell-activated, depolarizing chloride current (ICl,SWELL) in murine and human β-cells. Hypotonic and glucose-stimulated β-cell swelling activates SWELL1-mediated ICl,SWELL, contributing to membrane depolarization and activation of voltage-gated Ca2+ channels (VGCC)-dependent intracellular calcium signaling. β-cell-targeted Swell1 KO mice have impaired glucose-stimulated insulin secretion and glucose tolerance.","method":"Patch-clamp electrophysiology, tamoxifen-inducible β-cell Swell1 KO mice, calcium imaging, insulin secretion assay, glucose tolerance test","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — patch-clamp plus inducible cell-type-specific KO plus multiple physiological readouts, replicated in parallel by PMID:29773801","pmids":["29371604","29773801"],"is_preprint":false},{"year":2021,"finding":"Under hypertonic conditions, LRRC8A is phosphorylated and activated by MSK1 kinase downstream of the p38-MSK1 stress pathway. LRRC8A-mediated Cl- efflux then facilitates activation of the WNK kinase pathway, which promotes electrolyte influx via NKCC cotransporter for regulatory volume increase (RVI). The LRRC8A-S217A mutation impairs channel activation by MSK1, resulting in reduced RVI and cell survival. Identified by genome-wide CRISPR/Cas9 screen.","method":"Genome-wide CRISPR/Cas9 survival screen, site-directed mutagenesis (S217A), kinase assays, RVI volume measurements, NKCC inhibition","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — CRISPR screen plus mutagenesis of specific phosphosite plus pathway epistasis, multiple orthogonal methods","pmids":["34083438"],"is_preprint":false},{"year":2016,"finding":"LRRC8A physically co-localizes and co-immunoprecipitates with NADPH oxidase 1 (Nox1) and its p22phox subunit in vascular smooth muscle cells. LRRC8A is required for TNFα-induced extracellular superoxide production by Nox1, which in turn is essential for TNFR1 endocytosis, JNK phosphorylation, and NF-κB activation. LRRC8A siRNA reduces VRAC current and inhibits NF-κB-dependent inflammatory signaling.","method":"Co-immunoprecipitation, immunostaining co-localization, siRNA knockdown, superoxide assays (SOD inhibition), NF-κB reporter, receptor endocytosis assay","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus functional knockdown plus epistasis (extracellular SOD rescue), single lab","pmids":["27838438"],"is_preprint":false},{"year":2021,"finding":"LRRC8A physically interacts with NADPH oxidases Nox2, Nox4, and p22phox via its C-terminal leucine-rich repeat domain (LRRD). C-terminal LRRD mutant LRRC8A fails to co-immunoprecipitate with Nox2/Nox4/p22phox. LRRC8A knockdown suppresses AngII-induced ROS production, NADPH oxidase activity, and translocation of cytosolic subunits p47phox and p67phox, implicating LRRC8A-LRRD as the interface for Nox complex regulation in AngII-induced cardiac hypertrophy.","method":"Co-immunoprecipitation, domain-deletion mutant (LRRD), immunofluorescence co-localization, AAV9-siRNA in vivo knockdown, ROS/NADPH oxidase activity assays","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mutant plus functional KD, single lab, replicated interaction finding from PMID:27838438","pmids":["33515753"],"is_preprint":false},{"year":2021,"finding":"LRRC8A activates JAK2-STAT3 signaling via its C-terminal leucine-rich repeat domain (LRRD), which directly interacts with the adaptor protein GRB2. GRB2 is associated with and necessary for tyrosine-phosphorylated JAK2. This LRRC8A-GRB2-JAK2-STAT3 axis mediates TGF-β1-induced myofibroblast transformation and cardiac fibrosis following myocardial infarction. Myofibroblast-specific Lrrc8a KO attenuates fibrotic remodeling and ventricular dysfunction after MI.","method":"Co-immunoprecipitation, LRRD domain mutant, myofibroblast-specific conditional KO mice (periostin-Cre), RNA sequencing, immunoblot for JAK2/STAT3 phosphorylation","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mutant plus tissue-specific KO plus pathway analysis, single lab","pmids":["35966575"],"is_preprint":false},{"year":2017,"finding":"LRRC8A-containing VRAC in astrocytes shows subunit-dependent substrate specificity: LRRC8A/D-containing heteromers dominate release of uncharged osmolytes (taurine, myo-inositol), whereas LRRC8A/C/E-containing channels dominate release of charged osmolytes (D-aspartate). This demonstrates the existence of at least two distinct heteromeric VRACs in the same cell type.","method":"RNAi knockdown of individual LRRC8 subunits, radiotracer efflux assays (D-[14C]aspartate, [3H]taurine, myo-[3H]inositol)","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown of multiple subunits with multiple radiotracer substrates in same cells, single lab","pmids":["28833202"],"is_preprint":false},{"year":2017,"finding":"LRRC8A-LRRC8E heteromeric channels are dramatically activated (>10-fold) by oxidation of intracellular cysteine residues (by chloramine-T or tBHP), whereas LRRC8A-LRRC8C and LRRC8A-LRRC8D heteromers are strongly inhibited by oxidation. Endogenous VRAC currents in Jurkat T lymphocytes are inhibited by oxidation, consistent with their predominant LRRC8C/D expression. LRRC8 channel proteins are thus directly modulated by oxidation in a subunit-specific manner.","method":"Fluorescently-tagged constitutively active LRRC8 constructs, whole-cell patch-clamp, oxidant application (chloramine-T, tBHP), siRNA for subunit expression verification","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct pharmacological oxidation of defined heteromers with electrophysiology, consistent with endogenous cell data, single lab","pmids":["28841766"],"is_preprint":false},{"year":2020,"finding":"Intracellular LRRC8 proteins localize to lysosomes and generate lysosomal VRAC (Lyso-VRAC) currents in response to low cytoplasmic ionic strength. A double-leucine motif (L706L707) at the LRRC8A C-terminus is required for lysosomal targeting; mutation to alanines abolishes Lyso-VRAC but preserves plasma membrane VRAC. Lyso-VRAC is necessary for formation of lysosome-derived vacuoles that store and expel excess water. Selective elimination of Lyso-VRAC increases necrotic cell death under hypoosmotic, hypoxic, and hypothermic stress.","method":"Lysosome patch-clamp (whole-lysosome configuration), C-terminal targeting mutant (L706L707A), pharmacological tools, cell death assays","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct lysosomal electrophysiology plus specific targeting mutant that dissociates lysosomal from plasma membrane function, multiple stressors tested","pmids":["33139539"],"is_preprint":false},{"year":2018,"finding":"Germ cell-specific disruption of Lrrc8a leads to abnormal sperm morphology (cytoplasm swelling, disorganized mitochondrial sheaths, angulated/coiled flagella) and male infertility in mice, consistent with impaired cell volume regulation in late spermatids. Sertoli cell-specific disruption does not cause infertility, indicating a cell-autonomous requirement in germ cells.","method":"Germ cell-specific and Sertoli cell-specific Lrrc8a KO mice, electron microscopy, sperm morphology analysis, fertility testing","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with negative control (Sertoli-specific KO), electron microscopy, replicated across two papers (PMID:29880644, 30135305)","pmids":["29880644","30135305"],"is_preprint":false},{"year":2022,"finding":"NHE1 polarizes to the cell leading edge and SWELL1 polarizes to the cell trailing edge during confined migration. SWELL1 polarization confers migration direction and efficiency. Optogenetic RhoA activation at the cell front triggers SWELL1 redistribution and migration direction reversal in SWELL1-expressing but not SWELL1-knockdown cells. Dual NHE1/SWELL1 knockdown inhibits breast cancer extravasation and metastasis in vivo.","method":"Live-cell imaging, optogenetics (RhoA activation), siRNA knockdown, in vivo extravasation/metastasis model, mathematical modeling","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — optogenetic spatial control plus in vivo metastasis model, single lab, multiple orthogonal methods","pmids":["36253369"],"is_preprint":false},{"year":2021,"finding":"Endothelial LRRC8A (SWELL1) is required for VRAC in HUVECs and regulates AKT-eNOS signaling under basal, stretch, and shear-flow conditions. LRRC8A forms a GRB2-Cav1-eNOS signaling complex. Endothelium-restricted Lrrc8a KO mice develop hypertension upon chronic angiotensin-II infusion and exhibit impaired retinal blood flow in type 2 diabetes.","method":"Co-immunoprecipitation (GRB2-Cav1-eNOS complex with LRRC8A), endothelium-specific KO mice, patch-clamp, flow/stretch experiments, blood pressure telemetry, retinal angiography","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP signaling complex plus endothelium-specific KO with physiological readouts, single lab","pmids":["33629656"],"is_preprint":false},{"year":2020,"finding":"SWELL1 (LRRC8A) encodes a swell-activated anion channel in skeletal muscle cells that regulates PI3K-AKT, ERK1/2, and mTOR signaling, muscle differentiation, myoblast fusion, oxygen consumption, and glycolysis. LRRC8A overexpression in KO myotubes rescues myotube formation by boosting PI3K-AKT-mTOR signaling. Skeletal muscle-targeted KO mice have smaller myofibers, reduced force, decreased exercise endurance, increased adiposity, and glucose intolerance on high-fat diet.","method":"Skeletal muscle-specific Lrrc8a KO mice, LRRC8A overexpression rescue, patch-clamp, AKT/ERK/mTOR phosphoblot, myoblast fusion assay, metabolic/exercise phenotyping","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — tissue-specific KO plus rescue overexpression with signaling and physiological readouts, single lab","pmids":["32930093"],"is_preprint":false},{"year":2019,"finding":"LRRC8/VRAC channels are permeable to glutathione (GSH) with a PGSH/PCl ratio of ~0.1 under hypotonic conditions. LRRC8A KO cells show no GSH conductance. LRRC8/VRAC-mediated GSH efflux modulates intracellular ROS levels and contributes to TGFβ1-induced epithelial-to-mesenchymal transition (EMT); pharmacological (DCPIB) or siRNA inhibition of LRRC8A attenuates EMT by preserving intracellular GSH and reducing ROS.","method":"LRRC8A KO cells, GSH current measurement, intracellular GSH quantification, DCPIB inhibition, siRNA, EMT marker expression","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO cells plus pharmacological inhibition with PGSH/PCl ratio measurement, single lab","pmids":["31804464"],"is_preprint":false},{"year":2016,"finding":"LRRC8A downregulation in cisplatin-sensitive ovarian and alveolar carcinoma cells reduces p53 protein levels and downstream signaling (p21Waf1/Cip1, MDM2) and abolishes Caspase-9/-3 activation after cisplatin treatment. Cisplatin resistance correlates with reduced total LRRC8A expression (A2780) or reduced plasma membrane LRRC8A (A549). LRRC8A-dependent channel activity is upstream of cisplatin-induced apoptotic volume decrease.","method":"siRNA knockdown, pharmacological inhibition (NS3728, DIDS), immunoblot for p53/p21/MDM2/caspase activation, apoptosis assays","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA plus pharmacological inhibition with specific pathway readout, single lab","pmids":["26984736"],"is_preprint":false},{"year":2016,"finding":"Cisplatin accumulation in cells correlates with LRRC8A protein expression and VSOAC channel activity; cellular platinum content is high when VSOAC is activated and reduced when LRRC8A is silenced or pharmacologically inhibited. This demonstrates that LRRC8A-containing channels mediate cisplatin uptake.","method":"siRNA knockdown, ICP-MS platinum quantification, pharmacological inhibition, VRAC activation/inhibition","journal":"Journal of inorganic biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct platinum quantification (ICP-MS) with genetic and pharmacological manipulation, single lab","pmids":["27112899"],"is_preprint":false},{"year":2019,"finding":"LRRC8/VRAC promotes mouse myoblast differentiation by facilitating plasma membrane hyperpolarization early during differentiation. LRRC8A knockdown or pharmacological VRAC inhibition reduces myogenin expression and suppresses myoblast fusion without affecting proliferation. VRAC acts upstream of K+ channel activation; inhibition prevents early hyperpolarization and the subsequent increase in intracellular steady-state Ca2+ levels during myogenesis.","method":"siRNA knockdown of LRRC8A, pharmacological VRAC inhibition, membrane potential measurement, Ca2+ imaging, myogenin immunostaining, myotube formation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockdown plus pharmacological inhibition with mechanistic epistasis (hyperpolarization upstream of K+ channels), single lab","pmids":["31387946"],"is_preprint":false},{"year":2022,"finding":"In proximal tubules, LRRC8A and LRRC8D localize to basolateral membranes. Conditional deletion of LRRC8A in proximal (but not distal) tubules, and constitutive deletion of LRRC8D, cause proximal tubular injury, increased diuresis, and mild Fanconi-like symptoms. LRRC8C is exclusively found in vascular endothelium, and LRRC8E is specific for intercalated cells. These findings demonstrate that LRRC8A/D channels are required for basolateral exit of organic compounds in proximal tubules.","method":"Epitope-tagged LRRC8 knock-in mice (localization), conditional tubule-specific LRRC8A KO mice, constitutive LRRC8D KO, histology, urine/serum metabolomics","journal":"Journal of the American Society of Nephrology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific KO plus endogenous tagging for localization plus metabolomics, multiple genetic models","pmids":["35777784"],"is_preprint":false},{"year":2020,"finding":"LRRC8A is an essential regulator of hypotonicity-induced NLRP3 inflammasome activation in murine macrophages, but is dispensable for canonical DAMP-induced NLRP3 activation. Chemical, biochemical, and genetic (KO) approaches demonstrated this selective requirement. Canonical DAMP-dependent NLRP3 activation remains sensitive to chloride channel inhibitors, indicating additional chloride-sensing mechanisms.","method":"LRRC8A KO macrophages, VRAC pharmacological inhibitors, NLRP3 inflammasome activation assay (IL-1β/IL-18 secretion), ASC speck formation","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus pharmacological confirmation with clear negative result for DAMP pathway, single lab","pmids":["33216713"],"is_preprint":false},{"year":2024,"finding":"Phosphorylation of LRRC8A at Serine 174 (S174) acts as a checkpoint for VRAC activity in the steady state. ATP-evoked K+ efflux via P2X receptors alleviates S174 phosphorylation, thereby activating VRAC and potentiating cGAMP transport. Mutagenesis of S174 modulates the ATP responsiveness of LRRC8A channels.","method":"Site-directed mutagenesis (S174), P2X receptor agonist/antagonist, K+ efflux assays, cGAMP transport assay, VRAC electrophysiology","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis of specific phosphosite with functional assay, single lab","pmids":["38847616"],"is_preprint":false},{"year":2023,"finding":"LRRC8A channel inhibition in macrophages promotes phagocytosis by activating AMPK, inducing nuclear translocation of Nrf2, and increasing CD36 transcription. Conditional KO of Lrrc8a in macrophages accelerates hematoma clearance, reduces neuronal death, and improves functional recovery after intracerebral hemorrhagic stroke.","method":"Macrophage/microglia-specific Lrrc8a KO mice, AMPK inhibitor, Nrf2 nuclear translocation assay, CD36 expression, ICH mouse model, VRAC pharmacological inhibition","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific KO plus pathway inhibitors with in vivo disease model, single lab","pmids":["36465125"],"is_preprint":false},{"year":2021,"finding":"Brain-wide conditional deletion of LRRC8A causes fatal seizures in mice at 5–9 weeks of age. Hippocampal slice electrophysiology reveals increased pyramidal cell excitability and modified GABAergic inputs. LRRC8A-null hippocampi show decreased GLT-1, GAT-1, and glutamine synthetase protein levels, and reduced tissue glutamine, indicating that VRAC is required for normal astrocytic amino acid neurotransmitter homeostasis and brain excitability.","method":"NestinCre-driven brain-wide LRRC8A conditional KO, EEG/video seizure recording, brain slice patch-clamp, immunoblot, HPLC amino acid quantification","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — brain-specific KO with EEG confirmation, electrophysiology, and biochemical analysis, single lab","pmids":["34469026"],"is_preprint":false},{"year":2003,"finding":"A truncated form of LRRC8A (deletion of LRR7–9 at C-terminus), caused by chromosomal translocation, acts as a dominant negative to inhibit B cell development when expressed in murine bone marrow transplantation experiments. LRRC8A is expressed on T cells and B-lineage cells and is required for normal B cell development.","method":"Chromosomal translocation analysis, cDNA cloning, murine bone marrow transplantation with truncated LRRC8A expression, flow cytometry","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo bone marrow reconstitution experiment with defined truncation construct, single lab","pmids":["14660746"],"is_preprint":false},{"year":2018,"finding":"GlialCAM/MLC1 modulates LRRC8/VRAC currents indirectly: MLC1 cannot potentiate VRAC when LRRC8A is knocked down, but LRRC8A and MLC1 do not co-localize or co-immunoprecipitate and MLC1 does not potentiate LRRC8-mediated VRAC currents in Xenopus oocytes. Lack of MLC1 increases phosphorylation of LRRC8C (a VRAC subunit), and MLC1 overexpression reduces ERK phosphorylation, suggesting indirect modulation through signal transduction pathways.","method":"Co-immunoprecipitation (negative), Xenopus oocyte expression, LRRC8A siRNA knockdown, ERK phosphorylation immunoblot, LRRC8C phosphorylation assay","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis experiment plus negative co-IP plus phosphorylation assay, single lab; key result is that interaction is indirect","pmids":["30076890"],"is_preprint":false},{"year":2023,"finding":"LRRC8A associates with MPRIP (myosin phosphatase rho-interacting protein), confirmed by LRRC8A immunoprecipitation/mass spectrometry, confocal co-localization, proximity ligation assay, and IP/western blot. LRRC8A-MPRIP interaction links LRRC8A to RhoA-MYPT1-actin pathway; siLRRC8A or VRAC blockade decreases RhoA activity in VSMCs, and MYPT1 phosphorylation is reduced in VSMC-specific Lrrc8a KO mesenteries, contributing to enhanced vascular relaxation.","method":"Co-IP/mass spectrometry, proximity ligation assay, confocal imaging, VSMC-specific Lrrc8a KO mice, RhoA activity assay, MYPT1 phospho-immunoblot","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP/MS plus PLA plus functional KO with pathway readout, single lab","pmids":["37310356"],"is_preprint":false},{"year":2022,"finding":"LRRC8A channel quantification in cells: approximately 10,000 VRAC channels per cell based on quantitative immunoblot with recombinant protein calibration. LRRC8A immunoprecipitation co-precipitates an excess of non-LRRC8A subunits, suggesting these subunits predominate numerically in heterohexamers.","method":"Quantitative immunoblot with recombinant protein calibration, co-immunoprecipitation of all five LRRC8 subunits from multiple tissues","journal":"International journal of molecular sciences","confidence":"Low","confidence_rationale":"Tier 3 / Moderate — single co-IP method plus quantitative immunoblot; stoichiometry estimate is indirect","pmids":["31771171"],"is_preprint":false},{"year":2024,"finding":"BioID proximity labeling of LRRC8A identifies interactions with cell-cell junction proteins, calcium homeostasis regulators, kinases, and GTPase signaling components. Re-evaluation of LRRC8A in HCT116 LRRC8A-KO cells confirms no effect on cell proliferation or migration, consistent with PMID:31151189.","method":"BioID proximity-dependent biotinylation and mass spectrometry, LRRC8A-KO proliferation/migration assay","journal":"Cell death discovery","confidence":"Low","confidence_rationale":"Tier 3 / Weak — proximity labeling identifies candidate interactors but does not validate direct binding; single lab, single method for interactome","pmids":["38909013"],"is_preprint":false}],"current_model":"LRRC8A (SWELL1) is the obligatory subunit of the volume-regulated anion channel (VRAC), forming heterohexameric complexes (~800 kDa) with LRRC8B-E paralogues whose subunit composition determines anion/osmolyte selectivity, inactivation kinetics, and oxidant sensitivity; the hexameric structure, solved by cryo-EM and X-ray crystallography, reveals a connexin-like transmembrane pore with a cytoplasmic LRR domain that couples volume/ionic-strength sensing to gating, the N-termini fold into the pore forming a second selectivity filter, and DCPIB plugs the extracellular filter; beyond volume regulation, LRRC8A channels transport cGAMP, glutathione, glutamate, and cisplatin, signal through GRB2-PI3K-AKT and JAK2-STAT3 scaffolds via its C-terminal LRR domain, interact with Nox1/MPRIP complexes to regulate ROS and vascular tone, are activated by p38-MSK1 phosphorylation at S174/S217 during hypertonic stress, and localize to both the plasma membrane and lysosomes (directed by a C-terminal LL motif) where lysosomal VRAC supports osmotic homeostasis."},"narrative":{"mechanistic_narrative":"LRRC8A (SWELL1) is the obligatory, pore-forming subunit of the volume-regulated anion channel (VRAC), a heterohexameric complex it forms with LRRC8B–E paralogues that mediates regulatory volume decrease and the swelling-activated efflux of anions and organic osmolytes [PMID:24790029, PMID:24725410, PMID:26824658]. Genetic ablation eliminates VRAC currents, and reconstitution of LRRC8 complexes into lipid bilayers is sufficient to generate anion channels activated by osmolality gradients or by reduced cytoplasmic ionic strength [PMID:26824658]. Structural studies establish a connexin-like hexameric transmembrane pore constricted on the extracellular side by a selectivity filter, with a cytoplasmic leucine-rich repeat (LRR) domain that undergoes rigid-body dilation coupled to pore opening; the N-termini fold back into the pore to form a second selectivity filter, the inhibitor DCPIB plugs the extracellular filter, and subunit composition (e.g. the 4A:2C heterohexamer) tunes gating and activation [PMID:29769723, PMID:30775971, PMID:37543949, PMID:36928458, PMID:36522427]. Pore architecture is governed by the N-terminus, the TM2–TM3 intracellular loop, and residues such as E6, which control conductance, anion selectivity, and inactivation [PMID:29853476, PMID:29925591]. Subunit composition further determines substrate selectivity and oxidant sensitivity: distinct heteromers preferentially conduct charged versus uncharged osmolytes and are oppositely modulated by cysteine oxidation [PMID:28833202, PMID:28841766]. Channel activity is regulated by stress-kinase phosphorylation, with MSK1 acting at S217 to drive regulatory volume increase via the WNK–NKCC pathway and S174 phosphorylation serving as a steady-state checkpoint relieved by P2X-mediated K+ efflux [PMID:34083438, PMID:38847616]. Beyond volume regulation, LRRC8A channels transport diverse cargo — glutamate and excitatory amino acids in astrocytes, glutathione, cisplatin, and the immune second messenger cGAMP — linking VRAC to neurotransmission, redox balance, chemosensitivity, and STING-dependent interferon responses [PMID:25172945, PMID:32277911, PMID:33171122, PMID:30982627, PMID:31804464, PMID:27112899]. Through its C-terminal LRR domain, LRRC8A additionally scaffolds signaling: it binds GRB2 (with Cav1/eNOS) to govern insulin–PI3K–AKT and AKT–eNOS signaling, engages GRB2–JAK2–STAT3 in cardiac fibrosis, associates with Nox1/Nox2/Nox4–p22phox complexes to control ROS production, and binds MPRIP to modulate RhoA–MYPT1 signaling and vascular tone [PMID:28436964, PMID:27838438, PMID:33515753, PMID:35966575, PMID:33629656, PMID:37310356]. Tissue-specific deletions reveal physiological roles in adipocyte and β-cell glucose/insulin handling, skeletal muscle differentiation, spermatogenesis, proximal-tubule organic-compound transport, lysosomal osmotic homeostasis, and astrocytic neurotransmitter homeostasis, where brain-wide loss causes fatal seizures [PMID:28436964, PMID:30982627, PMID:29371604, PMID:29773801, PMID:33139539, PMID:29880644, PMID:30135305, PMID:32930093, PMID:35777784, PMID:34469026].","teleology":[{"year":2014,"claim":"Identified the long-sought molecular identity of VRAC, establishing LRRC8A as the essential pore-forming subunit whose loss abolishes swelling-activated anion currents.","evidence":"Two independent genome-wide siRNA screens with CRISPR genomic disruption, patch-clamp, and point mutagenesis altering anion selectivity","pmids":["24790029","24725410"],"confidence":"High","gaps":["Subunit stoichiometry and atomic architecture not yet defined","Mechanism coupling volume sensing to gating unresolved"]},{"year":2014,"claim":"Extended VRAC function beyond chloride to organic osmolyte and excitatory amino acid release, showing LRRC8A is required for both swelling- and receptor-triggered efflux.","evidence":"siRNA knockdown with radiotracer efflux assays in rat astrocytes","pmids":["25172945"],"confidence":"High","gaps":["Subunit composition determining osmolyte selectivity not defined here","Direct versus indirect permeation not distinguished"]},{"year":2014,"claim":"Revealed a non-channel signaling role, with LRRC8A scaffolding GRB2/GAB2/LCK to drive AKT activation and thymocyte development.","evidence":"Co-immunoprecipitation, Lrrc8a-/- phenotyping, bone marrow chimeras, phospho-AKT immunoblot","pmids":["24752297"],"confidence":"Medium","gaps":["Single lab","Relationship between channel activity and scaffolding function unresolved"]},{"year":2016,"claim":"Demonstrated that LRRC8 complexes are themselves the channel by reconstituting ~800 kDa heteromers into bilayers and showing low ionic strength activates them, defining the physical activating stimulus.","evidence":"Lipid bilayer reconstitution, single-channel electrophysiology, size-exclusion chromatography","pmids":["26824658"],"confidence":"High","gaps":["Atomic structure still absent","Physiological link between ionic strength sensing and cell volume not fully resolved"]},{"year":2016,"claim":"Linked LRRC8A to platinum drug handling and apoptosis, showing it mediates cisplatin uptake and is required for cisplatin-induced p53 and caspase activation.","evidence":"siRNA knockdown, ICP-MS platinum quantification, pharmacological inhibition, apoptosis assays","pmids":["27112899","26984736"],"confidence":"Medium","gaps":["Single lab studies","Direct cisplatin permeation through the pore not structurally demonstrated"]},{"year":2016,"claim":"Connected LRRC8A to redox and inflammatory signaling via physical association with Nox1/p22phox required for TNFα-induced superoxide and NF-κB activation.","evidence":"Co-IP, co-localization, siRNA, superoxide assays, NF-κB reporter in vascular smooth muscle cells","pmids":["27838438"],"confidence":"Medium","gaps":["Single lab","Whether interaction depends on channel conductance unclear"]},{"year":2017,"claim":"Established that subunit composition governs both substrate selectivity and oxidant sensitivity, explaining functional heterogeneity of VRACs within a single cell.","evidence":"Subunit-specific RNAi with radiotracer efflux; defined heteromer constructs with oxidant application and patch-clamp","pmids":["28833202","28841766"],"confidence":"Medium","gaps":["Single lab for each","Molecular basis of subunit-specific selectivity not structurally defined"]},{"year":2017,"claim":"Defined a metabolic signaling role, with the C-terminal LRR domain binding GRB2/Cav1 to control adipocyte insulin–PI3K–AKT2–GLUT4 signaling and systemic glycemia.","evidence":"Reciprocal co-IP with domain mutants, adipose-specific KO mice, glucose uptake and rescue assays","pmids":["28436964"],"confidence":"High","gaps":["Whether scaffolding requires channel activity not resolved","Single lab"]},{"year":2018,"claim":"Solved the hexameric, connexin-like channel architecture with an extracellular selectivity filter and cytoplasmic LRR arc adopting compact/relaxed conformations implicated in gating.","evidence":"Cryo-EM and X-ray crystallography of homomeric LRRC8A from independent labs","pmids":["29769723","30127360"],"confidence":"High","gaps":["Open/conductive state not captured","Heteromeric assembly architecture unknown"]},{"year":2018,"claim":"Mapped functional pore determinants to the N-terminus and the TM2–TM3 intracellular loop, identifying residues controlling conductance, selectivity, and inactivation.","evidence":"Chimeric and SCAM mutagenesis with patch-clamp and MTSES modification in LRRC8-null cells","pmids":["29853476","29925591"],"confidence":"High","gaps":["Structural visualization of N-termini in the pore not yet achieved here","How loops couple to LRR-driven gating unresolved"]},{"year":2018,"claim":"Demonstrated a cell-autonomous physiological requirement in germ cells, where Lrrc8a loss causes spermatid volume dysregulation and male infertility.","evidence":"Germ cell- and Sertoli cell-specific KO mice with electron microscopy and fertility testing","pmids":["29880644","30135305"],"confidence":"High","gaps":["Subunit partners in germ cells not defined","Molecular cargo relevant to spermatid volume not identified"]},{"year":2018,"claim":"Clarified GlialCAM/MLC1 modulation of VRAC as indirect via signaling rather than direct binding, refining the interactome.","evidence":"Negative co-IP, Xenopus oocyte expression, LRRC8A knockdown, ERK and LRRC8C phosphorylation assays","pmids":["30076890"],"confidence":"Medium","gaps":["Identity of the signaling intermediary unknown","Single lab"]},{"year":2019,"claim":"Captured an inhibitor-bound structure showing DCPIB plugs the extracellular filter and revealed lipid-dependent coupled dilation of LRRs and pore as a gating mechanism.","evidence":"Cryo-EM in lipid nanodiscs with DCPIB, constricted and expanded states","pmids":["30775971"],"confidence":"High","gaps":["Fully open conductive state not resolved","Direct link between LRR dilation and ionic-strength sensing not established"]},{"year":2019,"claim":"Established astrocytic VRAC as a mediator of non-vesicular glutamate release shaping synaptic transmission, memory, and ischemic injury.","evidence":"Astrocyte-specific Swell1 KO mice, patch-clamp, glutamate release assays, behavior, MCAO stroke model","pmids":["30982627"],"confidence":"High","gaps":["Subunit composition of astrocytic channel not defined","Single lab"]},{"year":2019,"claim":"Showed VRAC conducts glutathione, linking channel activity to intracellular ROS and TGFβ1-driven EMT.","evidence":"LRRC8A KO cells, GSH current and PGSH/PCl measurement, DCPIB and siRNA, EMT markers","pmids":["31804464"],"confidence":"Medium","gaps":["Single lab","Subunit determinants of GSH permeation not defined"]},{"year":2019,"claim":"Defined a role in myoblast differentiation through VRAC-driven membrane hyperpolarization upstream of K+ channels and Ca2+ signaling.","evidence":"siRNA, pharmacological VRAC inhibition, membrane potential and Ca2+ imaging, myogenin and fusion assays","pmids":["31387946"],"confidence":"Medium","gaps":["Single lab","Molecular mechanism connecting anion flux to hyperpolarization unresolved"]},{"year":2020,"claim":"Identified LRRC8A channels as transporters of the immune second messenger cGAMP across plasma membranes, enabling cell-to-cell STING-dependent interferon signaling and antiviral immunity.","evidence":"Transport assays, electrophysiology, LRRC8A and Lrrc8e KO/mice, CRISPR screen, STING reporters, HSV-1 challenge","pmids":["32277911","33171122"],"confidence":"High","gaps":["Directionality determinants in vivo incompletely defined","Role of LRRC8D inhibition mechanistically unexplained"]},{"year":2020,"claim":"Revealed a distinct lysosomal VRAC directed by a C-terminal di-leucine motif that supports osmotic homeostasis and protects against necrotic death under stress.","evidence":"Whole-lysosome patch-clamp, L706L707A targeting mutant dissociating lysosomal from plasma-membrane function, cell death assays","pmids":["33139539"],"confidence":"High","gaps":["Lysosomal subunit composition not defined","Single lab"]},{"year":2020,"claim":"Showed LRRC8A selectively required for hypotonicity-induced but not canonical DAMP-driven NLRP3 inflammasome activation, indicating additional chloride-sensing mechanisms.","evidence":"LRRC8A KO macrophages, VRAC inhibitors, IL-1β/IL-18 and ASC speck assays","pmids":["33216713"],"confidence":"Medium","gaps":["Identity of redundant chloride sensors unknown","Single lab"]},{"year":2020,"claim":"Established a skeletal muscle role coupling VRAC to PI3K–AKT–mTOR signaling, differentiation, metabolism, and exercise capacity.","evidence":"Muscle-specific KO mice, overexpression rescue, patch-clamp, signaling immunoblots, metabolic phenotyping","pmids":["32930093"],"confidence":"Medium","gaps":["Single lab","Whether metabolic effect requires anion conduction or scaffolding unresolved"]},{"year":2021,"claim":"Defined stress-kinase regulation, with p38–MSK1 phosphorylation at S217 activating VRAC to drive WNK–NKCC-dependent regulatory volume increase and survival.","evidence":"Genome-wide CRISPR survival screen, S217A mutagenesis, kinase assays, RVI and NKCC inhibition","pmids":["34083438"],"confidence":"High","gaps":["Structural consequence of S217 phosphorylation not defined","Single lab"]},{"year":2021,"claim":"Extended LRR-domain scaffolding to Nox2/Nox4–p22phox and GRB2–JAK2–STAT3 axes driving AngII cardiac hypertrophy and post-MI fibrosis.","evidence":"Co-IP with LRRD domain mutants, myofibroblast-specific KO, in vivo knockdown, ROS and phospho-signaling assays","pmids":["33515753","35966575"],"confidence":"Medium","gaps":["Single lab per study","Channel-independence of these signaling roles not formally shown"]},{"year":2021,"claim":"Defined endothelial LRRC8A in a GRB2–Cav1–eNOS complex regulating AKT–eNOS signaling, blood pressure, and diabetic retinal perfusion.","evidence":"Co-IP, endothelium-specific KO mice, patch-clamp, flow/stretch, blood pressure telemetry, retinal angiography","pmids":["33629656"],"confidence":"Medium","gaps":["Single lab","Mechanical activation mechanism not defined"]},{"year":2021,"claim":"Showed brain-wide VRAC is essential for astrocytic neurotransmitter homeostasis, with loss causing fatal seizures and dysregulated glutamate/GABA handling.","evidence":"NestinCre brain-wide KO, EEG/video, slice patch-clamp, immunoblot, HPLC amino acid quantification","pmids":["34469026"],"confidence":"Medium","gaps":["Single lab","Whether seizures arise from osmolyte transport or transporter expression changes not disentangled"]},{"year":2022,"claim":"Resolved heterohexameric LRRC8A:C architecture (4A:2C), showing flexible LRRC8C subunits destabilize closed-state A subunits to enhance activation and that pore lipids block conduction when closed.","evidence":"Cryo-EM with fiducial-tagged subunit identification and functional electrophysiology","pmids":["36928458","36522427"],"confidence":"High","gaps":["Structures of other heteromer compositions absent","Open-state structure of heteromer not captured"]},{"year":2022,"claim":"Implicated LRRC8A in directional confined migration, with RhoA-dependent trailing-edge polarization and a role in breast cancer extravasation and metastasis.","evidence":"Live-cell imaging, optogenetic RhoA activation, siRNA, in vivo metastasis model, modeling","pmids":["36253369"],"confidence":"Medium","gaps":["Single lab","Molecular link between RhoA and SWELL1 redistribution unresolved"]},{"year":2022,"claim":"Defined a renal physiological role, localizing LRRC8A/D to proximal tubule basolateral membranes required for organic compound exit, with loss causing Fanconi-like injury.","evidence":"Epitope-tagged knock-in localization, tubule-specific KO and constitutive LRRC8D KO, histology, urine/serum metabolomics","pmids":["35777784"],"confidence":"High","gaps":["Specific transported metabolites incompletely catalogued","Single lab"]},{"year":2023,"claim":"Resolved the channel N-termini folding into the pore as a second selectivity filter, with ionic-strength-dependent NT mobility providing a structural basis for activation.","evidence":"2.8-Å cryo-EM and molecular dynamics simulations","pmids":["37543949"],"confidence":"High","gaps":["Experimental validation of MD-predicted NT motions limited","Coupling between NT mobility and LRR dilation not fully integrated"]},{"year":2023,"claim":"Identified MPRIP as an LRRC8A partner linking the channel to RhoA–MYPT1–actin signaling and vascular relaxation.","evidence":"Co-IP/mass spectrometry, proximity ligation assay, confocal imaging, VSMC-specific KO, RhoA and MYPT1 assays","pmids":["37310356"],"confidence":"Medium","gaps":["Single lab","Direct versus complex-mediated binding not fully resolved"]},{"year":2023,"claim":"Showed LRRC8A inhibition in macrophages promotes phagocytosis via AMPK–Nrf2–CD36, improving outcomes after hemorrhagic stroke.","evidence":"Macrophage/microglia-specific KO, AMPK inhibitor, Nrf2 translocation, CD36 expression, ICH model","pmids":["36465125"],"confidence":"Medium","gaps":["Single lab","Mechanism connecting channel activity to AMPK unclear"]},{"year":2024,"claim":"Defined S174 phosphorylation as a steady-state checkpoint for VRAC, relieved by P2X-mediated K+ efflux to potentiate cGAMP transport.","evidence":"S174 mutagenesis, P2X agonist/antagonist, K+ efflux and cGAMP transport assays, electrophysiology","pmids":["38847616"],"confidence":"Medium","gaps":["Kinase/phosphatase acting on S174 not identified","Single lab"]},{"year":null,"claim":"How LRRC8A's channel conduction is mechanistically separable from its C-terminal LRR scaffolding functions, and what defines the open-state structure of native heteromeric channels, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No open conductive-state structure of a physiological heteromer","Channel-dependent versus -independent contributions to AKT/JAK2/Nox/RhoA signaling not cleanly dissected","In vivo subunit composition across tissues incompletely mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,9,12,13,27,29,31]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[11,19,25]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[2,3,5]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[16,33]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,12,22,25,31]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[22]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,1,12,13,27,29,31]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[16,22,33]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,12,13,32,34,36]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,19,25,38]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[9,14,35]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[23,26,30]}],"complexes":["VRAC (volume-regulated anion channel, LRRC8 heterohexamer)"],"partners":["LRRC8C","LRRC8D","LRRC8E","GRB2","CAV1","MPRIP","NOX1","EEF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8IWT6","full_name":"Volume-regulated anion channel subunit LRRC8A","aliases":["Leucine-rich repeat-containing protein 8A","HsLRRC8A","Swelling protein 1"],"length_aa":810,"mass_kda":94.2,"function":"Essential component of the volume-regulated anion channel (VRAC, also named VSOAC channel), an anion channel required to maintain a constant cell volume in response to extracellular or intracellular osmotic changes (PubMed:24725410, PubMed:24790029, PubMed:26530471, PubMed:26824658, PubMed:28193731, PubMed:29769723). The VRAC channel conducts iodide better than chloride and can also conduct organic osmolytes like taurine (PubMed:24725410, PubMed:24790029, PubMed:26530471, PubMed:26824658, PubMed:28193731, PubMed:30095067). Mediates efflux of amino acids, such as aspartate and glutamate, in response to osmotic stress (PubMed:28193731). LRRC8A and LRRC8D are required for the uptake of the drug cisplatin (PubMed:26530471). In complex with LRRC8C or LRRC8E, acts as a transporter of immunoreactive cyclic dinucleotide GMP-AMP (2'-3'-cGAMP), an immune messenger produced in response to DNA virus in the cytosol: mediates both import and export of 2'-3'-cGAMP, thereby promoting transfer of 2'-3'-cGAMP to bystander cells (PubMed:33171122). In contrast, complexes containing LRRC8D inhibit transport of 2'-3'-cGAMP (PubMed:33171122). Required for in vivo channel activity, together with at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E); channel characteristics depend on the precise subunit composition (PubMed:24790029, PubMed:26824658, PubMed:28193731). Can form functional channels by itself (in vitro) (PubMed:26824658). Involved in B-cell development: required for the pro-B cell to pre-B cell transition (PubMed:14660746). Also required for T-cell development (By similarity). Required for myoblast differentiation: VRAC activity promotes membrane hyperpolarization and regulates insulin-stimulated glucose metabolism and oxygen consumption (By similarity). Also acts as a regulator of glucose-sensing in pancreatic beta cells: VRAC currents, generated in response to hypotonicity- or glucose-induced beta cell swelling, depolarize cells, thereby causing electrical excitation, leading to increase glucose sensitivity and insulin secretion (PubMed:29371604). Also plays a role in lysosome homeostasis by forming functional lysosomal VRAC channels in response to low cytoplasmic ionic strength condition: lysosomal VRAC channels are necessary for the formation of large lysosome-derived vacuoles, which store and then expel excess water to maintain cytosolic water homeostasis (PubMed:31270356, PubMed:33139539). Acts as a key factor in NLRP3 inflammasome activation by modulating itaconate efflux and mitochondria function (PubMed:39909992)","subcellular_location":"Cell membrane; Lysosome membrane","url":"https://www.uniprot.org/uniprotkb/Q8IWT6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LRRC8A","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CANX","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/LRRC8A","total_profiled":1310},"omim":[{"mim_id":"613672","title":"SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4","url":"https://www.omim.org/entry/613672"},{"mim_id":"613669","title":"MITOCHONDRIAL POLY(A) POLYMERASE; MTPAP","url":"https://www.omim.org/entry/613669"},{"mim_id":"613506","title":"AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5","url":"https://www.omim.org/entry/613506"},{"mim_id":"612891","title":"LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8E; LRRC8E","url":"https://www.omim.org/entry/612891"},{"mim_id":"612890","title":"LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8D; LRRC8D","url":"https://www.omim.org/entry/612890"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/LRRC8A"},"hgnc":{"alias_symbol":["KIAA1437","FLJ10337","SWELL1"],"prev_symbol":["LRRC8"]},"alphafold":{"accession":"Q8IWT6","domains":[{"cath_id":"1.20.1440.80","chopping":"3-64_101-146_261-348","consensus_level":"medium","plddt":89.3501,"start":3,"end":348}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IWT6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IWT6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IWT6-F1-predicted_aligned_error_v6.png","plddt_mean":85.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LRRC8A","jax_strain_url":"https://www.jax.org/strain/search?query=LRRC8A"},"sequence":{"accession":"Q8IWT6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IWT6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IWT6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IWT6"}},"corpus_meta":[{"pmid":"24790029","id":"PMC_24790029","title":"Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC.","date":"2014","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/24790029","citation_count":517,"is_preprint":false},{"pmid":"24725410","id":"PMC_24725410","title":"SWELL1, a plasma membrane protein, is an essential component of volume-regulated anion channel.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/24725410","citation_count":482,"is_preprint":false},{"pmid":"32277911","id":"PMC_32277911","title":"Transfer of cGAMP into Bystander Cells via LRRC8 Volume-Regulated Anion Channels Augments STING-Mediated Interferon Responses and Anti-viral Immunity.","date":"2020","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/32277911","citation_count":244,"is_preprint":false},{"pmid":"26824658","id":"PMC_26824658","title":"LRRC8 Proteins Form Volume-Regulated Anion Channels that Sense Ionic Strength.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26824658","citation_count":213,"is_preprint":false},{"pmid":"30982627","id":"PMC_30982627","title":"Glutamate-Releasing SWELL1 Channel in Astrocytes Modulates Synaptic Transmission and Promotes Brain Damage in Stroke.","date":"2019","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/30982627","citation_count":191,"is_preprint":false},{"pmid":"33171122","id":"PMC_33171122","title":"LRRC8A:C/E Heteromeric Channels Are Ubiquitous Transporters of cGAMP.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33171122","citation_count":155,"is_preprint":false},{"pmid":"29769723","id":"PMC_29769723","title":"Structure of a volume-regulated anion channel of the LRRC8 family.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29769723","citation_count":155,"is_preprint":false},{"pmid":"28436964","id":"PMC_28436964","title":"SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.","date":"2017","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28436964","citation_count":144,"is_preprint":false},{"pmid":"22532330","id":"PMC_22532330","title":"LRRC8 proteins share a common ancestor with pannexins, and may form hexameric channels involved in cell-cell communication.","date":"2012","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22532330","citation_count":139,"is_preprint":false},{"pmid":"14660746","id":"PMC_14660746","title":"A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans.","date":"2003","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/14660746","citation_count":122,"is_preprint":false},{"pmid":"25172945","id":"PMC_25172945","title":"LRRC8A protein is indispensable for swelling-activated and ATP-induced release of excitatory amino acids in rat astrocytes.","date":"2014","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25172945","citation_count":113,"is_preprint":false},{"pmid":"24752297","id":"PMC_24752297","title":"Leucine-rich repeat containing 8A (LRRC8A) is essential for T lymphocyte development and function.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24752297","citation_count":106,"is_preprint":false},{"pmid":"27705766","id":"PMC_27705766","title":"Investigation of LRRC8-Mediated Volume-Regulated Anion Currents in Xenopus Oocytes.","date":"2016","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27705766","citation_count":100,"is_preprint":false},{"pmid":"30127360","id":"PMC_30127360","title":"Cryo-EM structures of the human volume-regulated anion channel LRRC8.","date":"2018","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30127360","citation_count":96,"is_preprint":false},{"pmid":"30775971","id":"PMC_30775971","title":"Cryo-EM structures of the DCPIB-inhibited volume-regulated anion channel LRRC8A in lipid nanodiscs.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30775971","citation_count":91,"is_preprint":false},{"pmid":"29371604","id":"PMC_29371604","title":"SWELL1 is a glucose sensor regulating β-cell excitability and systemic glycaemia.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29371604","citation_count":86,"is_preprint":false},{"pmid":"29773801","id":"PMC_29773801","title":"LRRC8/VRAC anion channels enhance β-cell glucose sensing and insulin secretion.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29773801","citation_count":85,"is_preprint":false},{"pmid":"28833202","id":"PMC_28833202","title":"Molecular composition and heterogeneity of the LRRC8-containing swelling-activated osmolyte channels in primary rat astrocytes.","date":"2017","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28833202","citation_count":85,"is_preprint":false},{"pmid":"30651298","id":"PMC_30651298","title":"A 30-year journey from volume-regulated anion currents to molecular structure of the LRRC8 channel.","date":"2019","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30651298","citation_count":82,"is_preprint":false},{"pmid":"26635246","id":"PMC_26635246","title":"VRAC: molecular identification as LRRC8 heteromers with differential functions.","date":"2015","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26635246","citation_count":70,"is_preprint":false},{"pmid":"33139539","id":"PMC_33139539","title":"LRRC8 family proteins within lysosomes regulate cellular osmoregulation and enhance cell survival to multiple physiological stresses.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33139539","citation_count":62,"is_preprint":false},{"pmid":"36253369","id":"PMC_36253369","title":"Polarized NHE1 and SWELL1 regulate migration direction, efficiency and metastasis.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36253369","citation_count":61,"is_preprint":false},{"pmid":"36632452","id":"PMC_36632452","title":"Upregulation of LRRC8A by m5C modification-mediated mRNA stability suppresses apoptosis and facilitates tumorigenesis in cervical cancer.","date":"2023","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36632452","citation_count":60,"is_preprint":false},{"pmid":"26254230","id":"PMC_26254230","title":"TMEM16, LRRC8A, bestrophin: chloride channels controlled by Ca(2+) and cell volume.","date":"2015","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26254230","citation_count":59,"is_preprint":false},{"pmid":"33629656","id":"PMC_33629656","title":"The SWELL1-LRRC8 complex regulates endothelial AKT-eNOS signaling and vascular function.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33629656","citation_count":58,"is_preprint":false},{"pmid":"32930093","id":"PMC_32930093","title":"SWELL1 regulates skeletal muscle cell size, intracellular signaling, adiposity and glucose metabolism.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32930093","citation_count":57,"is_preprint":false},{"pmid":"26984736","id":"PMC_26984736","title":"Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.","date":"2016","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26984736","citation_count":54,"is_preprint":false},{"pmid":"27112899","id":"PMC_27112899","title":"Dual role of LRRC8A-containing transporters on cisplatin resistance in human ovarian cancer cells.","date":"2016","source":"Journal of inorganic biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27112899","citation_count":51,"is_preprint":false},{"pmid":"28620305","id":"PMC_28620305","title":"Comparative Effects of Chloride Channel Inhibitors on LRRC8/VRAC-Mediated Chloride Conductance.","date":"2017","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28620305","citation_count":49,"is_preprint":false},{"pmid":"25868000","id":"PMC_25868000","title":"The volume-regulated anion channel is formed by LRRC8 heteromers – molecular identification and roles in membrane transport and physiology.","date":"2015","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25868000","citation_count":48,"is_preprint":false},{"pmid":"31091194","id":"PMC_31091194","title":"More than just a pressure relief valve: physiological roles of volume-regulated LRRC8 anion channels.","date":"2019","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31091194","citation_count":48,"is_preprint":false},{"pmid":"28841766","id":"PMC_28841766","title":"Subunit-dependent oxidative stress sensitivity of LRRC8 volume-regulated anion channels.","date":"2017","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28841766","citation_count":48,"is_preprint":false},{"pmid":"29957062","id":"PMC_29957062","title":"LRRC8A is essential for swelling-activated chloride current and for regulatory volume decrease in astrocytes.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29957062","citation_count":47,"is_preprint":false},{"pmid":"15094057","id":"PMC_15094057","title":"LRRC8 involved in B cell development belongs to a novel family of leucine-rich repeat proteins.","date":"2004","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15094057","citation_count":47,"is_preprint":false},{"pmid":"27838438","id":"PMC_27838438","title":"LRRC8A channels support TNFα-induced superoxide production by Nox1 which is required for receptor endocytosis.","date":"2016","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27838438","citation_count":44,"is_preprint":false},{"pmid":"28289711","id":"PMC_28289711","title":"The volume-regulated anion channel (LRRC8) in nodose neurons is sensitive to acidic pH.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/28289711","citation_count":42,"is_preprint":false},{"pmid":"33216713","id":"PMC_33216713","title":"LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33216713","citation_count":42,"is_preprint":false},{"pmid":"31151189","id":"PMC_31151189","title":"The Volume-Regulated Anion Channel LRRC8/VRAC Is Dispensable for Cell Proliferation and Migration.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31151189","citation_count":41,"is_preprint":false},{"pmid":"32598930","id":"PMC_32598930","title":"LRRC8A-dependent volume-regulated anion channels contribute to ischemia-induced brain injury and glutamatergic input to hippocampal neurons.","date":"2020","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32598930","citation_count":40,"is_preprint":false},{"pmid":"29853476","id":"PMC_29853476","title":"Intracellular and extracellular loops of LRRC8 are essential for volume-regulated anion channel function.","date":"2018","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29853476","citation_count":39,"is_preprint":false},{"pmid":"31597595","id":"PMC_31597595","title":"SWELL1 promotes cell growth and metastasis of hepatocellular carcinoma in vitro and in vivo.","date":"2019","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/31597595","citation_count":38,"is_preprint":false},{"pmid":"28192143","id":"PMC_28192143","title":"Leucine-rich repeat containing 8A (LRRC8A)-dependent volume-regulated anion channel activity is dispensable for T-cell development and function.","date":"2017","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28192143","citation_count":38,"is_preprint":false},{"pmid":"36928458","id":"PMC_36928458","title":"Structural basis for assembly and lipid-mediated gating of LRRC8A:C volume-regulated anion channels.","date":"2023","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/36928458","citation_count":37,"is_preprint":false},{"pmid":"35145074","id":"PMC_35145074","title":"Small molecule SWELL1 complex induction improves glycemic control and nonalcoholic fatty liver disease in murine Type 2 diabetes.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35145074","citation_count":37,"is_preprint":false},{"pmid":"26873248","id":"PMC_26873248","title":"Non-essential contribution of LRRC8A to volume regulation.","date":"2016","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26873248","citation_count":36,"is_preprint":false},{"pmid":"30076890","id":"PMC_30076890","title":"GlialCAM/MLC1 modulates LRRC8/VRAC currents in an indirect manner: Implications for megalencephalic leukoencephalopathy.","date":"2018","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/30076890","citation_count":35,"is_preprint":false},{"pmid":"32802190","id":"PMC_32802190","title":"Chronic ethanol consumption and HBV induce abnormal lipid metabolism through HBx/SWELL1/arachidonic acid signaling and activate Tregs in HBV-Tg mice.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32802190","citation_count":34,"is_preprint":false},{"pmid":"29880644","id":"PMC_29880644","title":"LRRC8/VRAC anion channels are required for late stages of spermatid development in mice.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29880644","citation_count":34,"is_preprint":false},{"pmid":"36522427","id":"PMC_36522427","title":"Structure of a volume-regulated heteromeric LRRC8A/C channel.","date":"2022","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/36522427","citation_count":33,"is_preprint":false},{"pmid":"27764579","id":"PMC_27764579","title":"Specific and essential but not sufficient roles of LRRC8A in the activity of volume-sensitive outwardly rectifying anion channel (VSOR).","date":"2016","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/27764579","citation_count":33,"is_preprint":false},{"pmid":"29925591","id":"PMC_29925591","title":"LRRC8 N termini influence pore properties and gating of volume-regulated anion channels (VRACs).","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29925591","citation_count":32,"is_preprint":false},{"pmid":"34083438","id":"PMC_34083438","title":"LRRC8A-containing chloride channel is crucial for cell volume recovery and survival under hypertonic conditions.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34083438","citation_count":31,"is_preprint":false},{"pmid":"31323188","id":"PMC_31323188","title":"LRRC8A Expression Influences Growth of Esophageal Squamous Cell Carcinoma.","date":"2019","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31323188","citation_count":30,"is_preprint":false},{"pmid":"33864161","id":"PMC_33864161","title":"LRRC8A influences the growth of gastric cancer cells via the p53 signaling pathway.","date":"2021","source":"Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association","url":"https://pubmed.ncbi.nlm.nih.gov/33864161","citation_count":30,"is_preprint":false},{"pmid":"33577730","id":"PMC_33577730","title":"Mechanisms of Activation of LRRC8 Volume Regulated Anion Channels.","date":"2021","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33577730","citation_count":29,"is_preprint":false},{"pmid":"27514381","id":"PMC_27514381","title":"Relationship between TMEM16A/anoctamin 1 and LRRC8A.","date":"2016","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27514381","citation_count":29,"is_preprint":false},{"pmid":"31181821","id":"PMC_31181821","title":"TTYH1 and TTYH2 Serve as LRRC8A-Independent Volume-Regulated Anion Channels in Cancer Cells.","date":"2019","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31181821","citation_count":28,"is_preprint":false},{"pmid":"30135305","id":"PMC_30135305","title":"Deficient LRRC8A-dependent volume-regulated anion channel activity is associated with male infertility in mice.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/30135305","citation_count":27,"is_preprint":false},{"pmid":"31804464","id":"PMC_31804464","title":"LRRC8/VRAC channels exhibit a noncanonical permeability to glutathione, which modulates epithelial-to-mesenchymal transition (EMT).","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31804464","citation_count":27,"is_preprint":false},{"pmid":"27688432","id":"PMC_27688432","title":"Leucine-rich repeat containing protein LRRC8A is essential for swelling-activated Cl- currents and embryonic development in zebrafish.","date":"2016","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/27688432","citation_count":27,"is_preprint":false},{"pmid":"31387946","id":"PMC_31387946","title":"The LRRC8/VRAC anion channel facilitates myogenic differentiation of murine myoblasts by promoting membrane hyperpolarization.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31387946","citation_count":26,"is_preprint":false},{"pmid":"31814333","id":"PMC_31814333","title":"The LRRC8 volume-regulated anion channel inhibitor, DCPIB, inhibits mitochondrial respiration independently of the channel.","date":"2019","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/31814333","citation_count":25,"is_preprint":false},{"pmid":"33515753","id":"PMC_33515753","title":"LRRC8A contributes to angiotensin II-induced cardiac hypertrophy by interacting with NADPH oxidases via the C-terminal leucine-rich repeat domain.","date":"2021","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33515753","citation_count":25,"is_preprint":false},{"pmid":"33356947","id":"PMC_33356947","title":"LRRC8A homohexameric channels poorly recapitulate VRAC regulation and pharmacology.","date":"2020","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33356947","citation_count":23,"is_preprint":false},{"pmid":"35966575","id":"PMC_35966575","title":"LRRC8A critically regulates myofibroblast phenotypes and fibrotic remodeling following myocardial infarction.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/35966575","citation_count":23,"is_preprint":false},{"pmid":"37925509","id":"PMC_37925509","title":"Cell volume controlled by LRRC8A-formed volume-regulated anion channels fine-tunes T cell activation and function.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37925509","citation_count":22,"is_preprint":false},{"pmid":"28873008","id":"PMC_28873008","title":"Induction of adipose and hepatic SWELL1 expression is required for maintaining systemic insulin-sensitivity in obesity.","date":"2017","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/28873008","citation_count":22,"is_preprint":false},{"pmid":"33932953","id":"PMC_33932953","title":"Oxidant-resistant LRRC8A/C anion channels support superoxide production by NADPH oxidase 1.","date":"2021","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33932953","citation_count":22,"is_preprint":false},{"pmid":"39294178","id":"PMC_39294178","title":"Activation of osmo-sensitive LRRC8 anion channels in macrophages is important for micro-crystallin joint inflammation.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39294178","citation_count":21,"is_preprint":false},{"pmid":"31390227","id":"PMC_31390227","title":"CysLT1 receptor antagonists pranlukast and zafirlukast inhibit LRRC8-mediated volume regulated anion channels independently of the receptor.","date":"2019","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31390227","citation_count":21,"is_preprint":false},{"pmid":"35504105","id":"PMC_35504105","title":"Regulators of cell volume: The structural and functional properties of anion channels of the LRRC8 family.","date":"2022","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/35504105","citation_count":20,"is_preprint":false},{"pmid":"36035259","id":"PMC_36035259","title":"Structure-function relationships of the LRRC8 subunits and subdomains of the volume-regulated anion channel (VRAC).","date":"2022","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36035259","citation_count":20,"is_preprint":false},{"pmid":"35777784","id":"PMC_35777784","title":"Renal Deletion of LRRC8/VRAC Channels Induces Proximal Tubulopathy.","date":"2022","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/35777784","citation_count":20,"is_preprint":false},{"pmid":"33827893","id":"PMC_33827893","title":"Regulation of Anion Channel LRRC8 Volume-Regulated Anion Channels in Transport of 2'3'-Cyclic GMP-AMP and Cisplatin under Steady State and Inflammation.","date":"2021","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/33827893","citation_count":20,"is_preprint":false},{"pmid":"30252954","id":"PMC_30252954","title":"Hypotonic stress response of human keratinocytes involves LRRC8A as component of volume-regulated anion channels.","date":"2018","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/30252954","citation_count":19,"is_preprint":false},{"pmid":"31771171","id":"PMC_31771171","title":"Absolute Protein Amounts and Relative Abundance of Volume-regulated Anion Channel (VRAC) LRRC8 Subunits in Cells and Tissues Revealed by Quantitative Immunoblotting.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31771171","citation_count":19,"is_preprint":false},{"pmid":"31127489","id":"PMC_31127489","title":"Inhibition of angiotensin II-induced cerebrovascular smooth muscle cell proliferation by LRRC8A downregulation through suppressing PI3K/AKT activation.","date":"2019","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/31127489","citation_count":19,"is_preprint":false},{"pmid":"34469026","id":"PMC_34469026","title":"Late adolescence mortality in mice with brain-specific deletion of the volume-regulated anion channel subunit LRRC8A.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/34469026","citation_count":18,"is_preprint":false},{"pmid":"37543949","id":"PMC_37543949","title":"Structural insights into anion selectivity and activation mechanism of LRRC8 volume-regulated anion channels.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37543949","citation_count":17,"is_preprint":false},{"pmid":"27579940","id":"PMC_27579940","title":"Distinct contributions of LRRC8A and its paralogs to the VSOR anion channel from those of the ASOR anion channel.","date":"2016","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/27579940","citation_count":17,"is_preprint":false},{"pmid":"39056405","id":"PMC_39056405","title":"The SWELL1 Channel Promotes Ischemic Brain Damage by Mediating Neuronal Swelling and Glutamate Toxicity.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39056405","citation_count":16,"is_preprint":false},{"pmid":"37310356","id":"PMC_37310356","title":"LRRC8A anion channels modulate vascular reactivity via association with myosin phosphatase rho interacting protein.","date":"2023","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/37310356","citation_count":16,"is_preprint":false},{"pmid":"36465125","id":"PMC_36465125","title":"Inhibition of the LRRC8A channel promotes microglia/macrophage phagocytosis and improves outcomes after intracerebral hemorrhagic stroke.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/36465125","citation_count":16,"is_preprint":false},{"pmid":"35150591","id":"PMC_35150591","title":"LRRC8A is dispensable for a variety of microglial functions and response to acute stroke.","date":"2022","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/35150591","citation_count":16,"is_preprint":false},{"pmid":"37182109","id":"PMC_37182109","title":"Conditional deletion of LRRC8A in the brain reduces stroke damage independently of swelling-activated glutamate release.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37182109","citation_count":16,"is_preprint":false},{"pmid":"28121479","id":"PMC_28121479","title":"Cisplatin activates volume sensitive LRRC8 channel mediated currents in Xenopus oocytes.","date":"2017","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/28121479","citation_count":16,"is_preprint":false},{"pmid":"35645818","id":"PMC_35645818","title":"Recent Advances in the Structural Biology of the Volume-Regulated Anion Channel LRRC8.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35645818","citation_count":15,"is_preprint":false},{"pmid":"38909013","id":"PMC_38909013","title":"Interactomic exploration of LRRC8A in volume-regulated anion channels.","date":"2024","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/38909013","citation_count":14,"is_preprint":false},{"pmid":"33476655","id":"PMC_33476655","title":"Volume-regulated chloride channel regulates cell proliferation and is involved in the possible interaction between TMEM16A and LRRC8A in human metastatic oral squamous cell carcinoma cells.","date":"2021","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33476655","citation_count":14,"is_preprint":false},{"pmid":"36511337","id":"PMC_36511337","title":"Activation of Swell1 in microglia suppresses neuroinflammation and reduces brain damage in ischemic stroke.","date":"2022","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/36511337","citation_count":13,"is_preprint":false},{"pmid":"36467895","id":"PMC_36467895","title":"Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy.","date":"2022","source":"Cancer research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36467895","citation_count":13,"is_preprint":false},{"pmid":"30426452","id":"PMC_30426452","title":"LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway.","date":"2018","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/30426452","citation_count":13,"is_preprint":false},{"pmid":"38847616","id":"PMC_38847616","title":"ATP-elicited Cation Fluxes Promote Volume-regulated Anion Channel LRRC8/VRAC Transport cGAMP for Antitumor Immunity.","date":"2024","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/38847616","citation_count":12,"is_preprint":false},{"pmid":"38350542","id":"PMC_38350542","title":"LRRC8A as a central mediator promotes colon cancer metastasis by regulating PIP5K1B/PIP2 pathway.","date":"2024","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/38350542","citation_count":12,"is_preprint":false},{"pmid":"30931966","id":"PMC_30931966","title":"The LRRC8-mediated volume-regulated anion channel is altered in glaucoma.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30931966","citation_count":12,"is_preprint":false},{"pmid":"33335902","id":"PMC_33335902","title":"Ca2+ Dependence of Volume-Regulated VRAC/LRRC8 and TMEM16A Cl- Channels.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33335902","citation_count":12,"is_preprint":false},{"pmid":"34725866","id":"PMC_34725866","title":"LRRC8A is essential for volume-regulated anion channel in smooth muscle cells contributing to cerebrovascular remodeling during hypertension.","date":"2021","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/34725866","citation_count":12,"is_preprint":false},{"pmid":"29498698","id":"PMC_29498698","title":"Expression of LRRC8/VRAC Currents in Xenopus Oocytes: Advantages and Caveats.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29498698","citation_count":11,"is_preprint":false},{"pmid":"33711227","id":"PMC_33711227","title":"LRRC8/VRAC Channels and the Redox Balance: A Complex Relationship.","date":"2021","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33711227","citation_count":11,"is_preprint":false},{"pmid":"32892951","id":"PMC_32892951","title":"LRRC8 channel activation and reduction in cytosolic chloride concentration during early differentiation of C2C12 myoblasts.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32892951","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50793,"output_tokens":11859,"usd":0.165132,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":22787,"output_tokens":8330,"usd":0.161092,"stage2_stop_reason":"end_turn"},"total_usd":0.326224,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2014,\n      \"finding\": \"LRRC8A (SWELL1) is an essential component of the volume-regulated anion channel (VRAC). Genome-wide RNAi screens independently identified LRRC8A as required for hypotonicity-induced iodide influx and VRAC currents. Genomic disruption of LRRC8A ablated VRAC currents, and point mutations in LRRC8A cause significant changes in VRAC anion selectivity, demonstrating that LRRC8A is a pore-forming component. LRRC8A forms heteromers with other LRRC8 family members (LRRC8B-E), and the isoform combination determines VRAC inactivation kinetics. Taurine flux and regulatory volume decrease also depend on LRRC8 proteins.\",\n      \"method\": \"Genome-wide siRNA screen, CRISPR genomic disruption, patch-clamp electrophysiology, taurine flux assay, point mutagenesis\",\n      \"journal\": \"Science / Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — two independent genome-wide screens, genomic disruption, patch-clamp, mutagenesis, replicated across two labs simultaneously\",\n      \"pmids\": [\"24790029\", \"24725410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LRRC8 proteins together constitute the VRAC pore. SWELL1 and up to four other LRRC8 subunits assemble into heterogeneous complexes of ~800 kDa. When reconstituted into lipid bilayers, LRRC8 complexes are sufficient to form anion channels activated by osmolality gradients. Single-channel conductance depends on LRRC8 subunit composition. Low ionic strength in the absence of an osmotic gradient activates the complexes in bilayers, demonstrating that hypotonic stress can activate VRAC through a decrease in cytoplasmic ionic strength.\",\n      \"method\": \"Reconstitution into lipid bilayers, single-channel electrophysiology, size-exclusion chromatography (~800 kDa complex), patch-clamp\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution in bilayers with functional readout, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"26824658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cryo-EM and X-ray crystallography of homomeric LRRC8A reveal a hexameric channel architecture. The transmembrane domain is structurally related to connexin proteins, wide towards the cytoplasm but constricted on the extracellular side by a selectivity filter. An excess of basic residues in the filter and throughout the pore attracts anions by electrostatic interaction. The cytoplasmic leucine-rich repeat domain follows the transmembrane pore domain.\",\n      \"method\": \"Cryo-electron microscopy, X-ray crystallography\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution structure by two independent methods (cryo-EM and X-ray crystallography) in a single study; replicated by multiple labs\",\n      \"pmids\": [\"29769723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cryo-EM structure of human LRRC8A shows a hexameric assembly. The transmembrane region features topology similar to gap junction channels. The LRR region (15 leucine-rich repeats) forms a long twisted arc. The channel pore is constricted on the extracellular side, where conserved polar and charged residues at the tip of the extracellular helix contribute to anion permeability. Two structural populations (compact and relaxed conformations) suggest that the LRR region undergoes rigid-body motions possibly implicated in pore opening.\",\n      \"method\": \"Single-particle cryo-electron microscopy\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure of human LRRC8A, replicates and extends Nature 2018 structure from a second independent lab\",\n      \"pmids\": [\"30127360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cryo-EM structures of LRRC8A in lipid nanodiscs with the inhibitor DCPIB show that DCPIB plugs the channel in the extracellular selectivity filter, sterically occluding ion conduction. Constricted and expanded structures reveal coupled dilation of cytoplasmic LRRs and the channel pore, suggesting a gating mechanism by internal stimuli. Conformational differences between detergent and lipid bilayer structures demonstrate a critical role for the membrane lipid environment in determining channel structure, including intersubunit lipid binding sites.\",\n      \"method\": \"Single-particle cryo-electron microscopy, lipid nanodisc reconstitution, inhibitor-bound structure\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution inhibitor-bound cryo-EM structure in native-like lipid bilayer environment with conformational analysis\",\n      \"pmids\": [\"30775971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The intracellular loop (IL) connecting TM2 and TM3 of LRRC8A and the first extracellular loop (EL1) of LRRC8C/D/E are both essential for VRAC activity. A 25-amino acid sequence unique to the LRRC8A IL is sufficient to generate homomeric VRAC activity when inserted into LRRC8C or LRRC8E. LRRC8 chimeras containing partial LRRC8A IL sequences exhibit altered anion permeability, rectification, and voltage sensitivity, indicating that the LRRC8A IL contributes to pore structure and function.\",\n      \"method\": \"Chimeric channel mutagenesis, patch-clamp electrophysiology in LRRC8-/- cells\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic chimera/mutagenesis combined with functional electrophysiology, multiple constructs tested\",\n      \"pmids\": [\"29853476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The short N-terminal stretch preceding the first LRRC8 transmembrane domain determines VRAC conductance, ion permeability, and inactivation gating. Substituted-cysteine accessibility studies reveal that the first 15 LRRC8A residues are exposed to a hydrophilic environment. Glutamate 6 (E6) controls iodide-over-chloride permeability and voltage dependence of inactivation; restoring the negative charge by MTSES reverses these effects. Cd2+-mediated blocking data suggest the N termini come close together in the multimeric complex and may line the cytoplasmic pore.\",\n      \"method\": \"Substituted-cysteine accessibility method (SCAM), site-directed mutagenesis, patch-clamp, MTSES modification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — SCAM plus mutagenesis plus electrophysiology, multiple orthogonal approaches in one study\",\n      \"pmids\": [\"29925591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"2.8-Å cryo-EM structure of human LRRC8A shows well-resolved N-termini (NTs). The amino-terminal halves of NTs fold back into the pore and constrict the permeation path, forming a second selectivity filter working in series with the extracellular selectivity filter. The C-terminal halves of NTs interact with intracellular loops crucial for channel activation. Molecular dynamics simulations indicate that low ionic strength increases NT mobility and expands inter-helix distances, suggesting a mechanism for VRAC activation.\",\n      \"method\": \"Single-particle cryo-EM (2.8 Å), molecular dynamics simulations\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — near-atomic resolution structure with MD simulations providing mechanistic insight into activation and selectivity\",\n      \"pmids\": [\"37543949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cryo-EM structures of heterohexameric LRRC8A:C channels reveal a predominant assembly with A:C ratio of 2:4 (four LRRC8A and two LRRC8C subunits). Four LRRC8A subunits cluster in their preferred closed-state conformation as pairs. The two LRRC8C subunits show greater flexibility, destabilizing the tightly packed A subunits and enhancing activation. Lipids embedded in the channel pore block ion conduction in the closed state.\",\n      \"method\": \"Single-particle cryo-EM, fiducial-tagging strategy for subunit identification, functional electrophysiology\",\n      \"journal\": \"Nature structural & molecular biology / Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic cryo-EM structures of heteromeric channel in multiple conformations, replicated across two papers (28928458, 36522427)\",\n      \"pmids\": [\"36928458\", \"36522427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LRRC8A is an indispensable component of the swelling-activated excitatory amino acid (EAA) release pathway in rat astrocytes. siRNA knockdown of LRRC8A dramatically reduced hypo-osmotic release of D-[3H]aspartate, L-glutamate, and taurine, and completely abolished ATP-stimulated release of EAAs and taurine from non-swollen astrocytes.\",\n      \"method\": \"siRNA knockdown, radiotracer efflux assays (D-[3H]aspartate, [14C]taurine), HPLC\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with multiple radiotracer substrates and HPLC confirmation, specific to LRRC8A\",\n      \"pmids\": [\"25172945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LRRC8A constitutively associates with the GRB2-GAB2 complex and lymphocyte-specific protein tyrosine kinase (LCK) in thymocytes. LRRC8A ligation activates AKT via the LCK-ZAP-70-GAB2-PI3K pathway, and AKT phosphorylation is markedly reduced in Lrrc8a-/- thymus. Thymic epithelial cells express an LRRC8A ligand critical for double-negative to double-positive thymocyte differentiation and survival in vitro.\",\n      \"method\": \"Co-immunoprecipitation, Lrrc8a-/- mouse phenotyping, bone marrow chimeras, flow cytometry, phospho-AKT immunoblot\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP and genetic KO with signaling readout, but single lab\",\n      \"pmids\": [\"24752297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SWELL1/LRRC8A regulates adipocyte insulin-PI3K-AKT2-GLUT4 signaling, glucose uptake, and lipid content via interactions of the SWELL1 C-terminal leucine-rich repeat domain (LRRD) with GRB2 and Cav1. Silencing GRB2 in SWELL1 KO adipocytes rescues insulin-pAKT2 signaling. In vivo, adipose-targeted SWELL1 KO reduces adiposity and impairs systemic glycemia and insulin sensitivity.\",\n      \"method\": \"Co-immunoprecipitation (LRRD-GRB2/Cav1 interaction), adipose-specific KO mice, patch-clamp, glucose uptake assay, siRNA rescue\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, specific domain mutant, tissue-specific KO in vivo, rescue experiment, multiple orthogonal methods\",\n      \"pmids\": [\"28436964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LRRC8A/LRRC8E-containing VRACs transport cGAMP and cyclic dinucleotides across the plasma membrane, enabling cell-to-cell transmission of the innate immune second messenger cGAMP. Chemical blockade or genetic ablation of LRRC8A results in defective interferon responses to HSV-1. Enhancing VRAC activity by hypotonic swelling, cisplatin, GTPγS, or cytokines (TNF, IL-1) increases STING-dependent IFN responses to extracellular cGAMP. Lrrc8e-/- mice exhibit impaired IFN responses and compromised immunity to HSV-1.\",\n      \"method\": \"Biochemical transport assay, electrophysiology, genetic ablation (LRRC8A KO, Lrrc8e-/- mice), IFN ELISA, viral challenge\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — electrophysiology plus biochemical transport assay plus in vivo genetic model, multiple orthogonal methods\",\n      \"pmids\": [\"32277911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LRRC8A forms complexes with LRRC8C and/or LRRC8E to transport cGAMP and other 2'3'-cyclic dinucleotides as an importer or exporter depending on the electrochemical gradient. LRRC8D inhibits cGAMP transport. Activation of LRRC8A channels by sphingosine 1-phosphate potentiates cGAMP transport. LRRC8A channels are the key cGAMP transporters in resting primary human vasculature cells.\",\n      \"method\": \"Genome-wide CRISPR screen, cGAMP transport assay, STING reporter assay, pharmacological activation/inhibition (S1P, DCPIB)\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR screen plus mechanistic transport assays with activators/inhibitors, replicated findings from PMID:32277911\",\n      \"pmids\": [\"33171122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Astrocytic SWELL1/LRRC8A mediates non-vesicular glutamate release through VRAC. Both cell swelling and receptor stimulation activate astrocytic VRAC, which requires SWELL1. Astrocyte-specific Swell1 KO mice exhibit impaired glutamatergic transmission (reduced presynaptic release probability and ambient glutamate), hippocampal-dependent learning/memory deficits, and attenuated neuronal excitability and brain damage after ischemic stroke.\",\n      \"method\": \"Astrocyte-specific conditional KO mice, whole-cell patch-clamp, glutamate release assay, behavioral testing, ischemia model (MCAO)\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific KO with multiple orthogonal functional readouts (electrophysiology, neurochemistry, behavior, in vivo stroke model)\",\n      \"pmids\": [\"30982627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SWELL1 mediates a swell-activated, depolarizing chloride current (ICl,SWELL) in murine and human β-cells. Hypotonic and glucose-stimulated β-cell swelling activates SWELL1-mediated ICl,SWELL, contributing to membrane depolarization and activation of voltage-gated Ca2+ channels (VGCC)-dependent intracellular calcium signaling. β-cell-targeted Swell1 KO mice have impaired glucose-stimulated insulin secretion and glucose tolerance.\",\n      \"method\": \"Patch-clamp electrophysiology, tamoxifen-inducible β-cell Swell1 KO mice, calcium imaging, insulin secretion assay, glucose tolerance test\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — patch-clamp plus inducible cell-type-specific KO plus multiple physiological readouts, replicated in parallel by PMID:29773801\",\n      \"pmids\": [\"29371604\", \"29773801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Under hypertonic conditions, LRRC8A is phosphorylated and activated by MSK1 kinase downstream of the p38-MSK1 stress pathway. LRRC8A-mediated Cl- efflux then facilitates activation of the WNK kinase pathway, which promotes electrolyte influx via NKCC cotransporter for regulatory volume increase (RVI). The LRRC8A-S217A mutation impairs channel activation by MSK1, resulting in reduced RVI and cell survival. Identified by genome-wide CRISPR/Cas9 screen.\",\n      \"method\": \"Genome-wide CRISPR/Cas9 survival screen, site-directed mutagenesis (S217A), kinase assays, RVI volume measurements, NKCC inhibition\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — CRISPR screen plus mutagenesis of specific phosphosite plus pathway epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"34083438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LRRC8A physically co-localizes and co-immunoprecipitates with NADPH oxidase 1 (Nox1) and its p22phox subunit in vascular smooth muscle cells. LRRC8A is required for TNFα-induced extracellular superoxide production by Nox1, which in turn is essential for TNFR1 endocytosis, JNK phosphorylation, and NF-κB activation. LRRC8A siRNA reduces VRAC current and inhibits NF-κB-dependent inflammatory signaling.\",\n      \"method\": \"Co-immunoprecipitation, immunostaining co-localization, siRNA knockdown, superoxide assays (SOD inhibition), NF-κB reporter, receptor endocytosis assay\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus functional knockdown plus epistasis (extracellular SOD rescue), single lab\",\n      \"pmids\": [\"27838438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LRRC8A physically interacts with NADPH oxidases Nox2, Nox4, and p22phox via its C-terminal leucine-rich repeat domain (LRRD). C-terminal LRRD mutant LRRC8A fails to co-immunoprecipitate with Nox2/Nox4/p22phox. LRRC8A knockdown suppresses AngII-induced ROS production, NADPH oxidase activity, and translocation of cytosolic subunits p47phox and p67phox, implicating LRRC8A-LRRD as the interface for Nox complex regulation in AngII-induced cardiac hypertrophy.\",\n      \"method\": \"Co-immunoprecipitation, domain-deletion mutant (LRRD), immunofluorescence co-localization, AAV9-siRNA in vivo knockdown, ROS/NADPH oxidase activity assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mutant plus functional KD, single lab, replicated interaction finding from PMID:27838438\",\n      \"pmids\": [\"33515753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LRRC8A activates JAK2-STAT3 signaling via its C-terminal leucine-rich repeat domain (LRRD), which directly interacts with the adaptor protein GRB2. GRB2 is associated with and necessary for tyrosine-phosphorylated JAK2. This LRRC8A-GRB2-JAK2-STAT3 axis mediates TGF-β1-induced myofibroblast transformation and cardiac fibrosis following myocardial infarction. Myofibroblast-specific Lrrc8a KO attenuates fibrotic remodeling and ventricular dysfunction after MI.\",\n      \"method\": \"Co-immunoprecipitation, LRRD domain mutant, myofibroblast-specific conditional KO mice (periostin-Cre), RNA sequencing, immunoblot for JAK2/STAT3 phosphorylation\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mutant plus tissue-specific KO plus pathway analysis, single lab\",\n      \"pmids\": [\"35966575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LRRC8A-containing VRAC in astrocytes shows subunit-dependent substrate specificity: LRRC8A/D-containing heteromers dominate release of uncharged osmolytes (taurine, myo-inositol), whereas LRRC8A/C/E-containing channels dominate release of charged osmolytes (D-aspartate). This demonstrates the existence of at least two distinct heteromeric VRACs in the same cell type.\",\n      \"method\": \"RNAi knockdown of individual LRRC8 subunits, radiotracer efflux assays (D-[14C]aspartate, [3H]taurine, myo-[3H]inositol)\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown of multiple subunits with multiple radiotracer substrates in same cells, single lab\",\n      \"pmids\": [\"28833202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LRRC8A-LRRC8E heteromeric channels are dramatically activated (>10-fold) by oxidation of intracellular cysteine residues (by chloramine-T or tBHP), whereas LRRC8A-LRRC8C and LRRC8A-LRRC8D heteromers are strongly inhibited by oxidation. Endogenous VRAC currents in Jurkat T lymphocytes are inhibited by oxidation, consistent with their predominant LRRC8C/D expression. LRRC8 channel proteins are thus directly modulated by oxidation in a subunit-specific manner.\",\n      \"method\": \"Fluorescently-tagged constitutively active LRRC8 constructs, whole-cell patch-clamp, oxidant application (chloramine-T, tBHP), siRNA for subunit expression verification\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct pharmacological oxidation of defined heteromers with electrophysiology, consistent with endogenous cell data, single lab\",\n      \"pmids\": [\"28841766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Intracellular LRRC8 proteins localize to lysosomes and generate lysosomal VRAC (Lyso-VRAC) currents in response to low cytoplasmic ionic strength. A double-leucine motif (L706L707) at the LRRC8A C-terminus is required for lysosomal targeting; mutation to alanines abolishes Lyso-VRAC but preserves plasma membrane VRAC. Lyso-VRAC is necessary for formation of lysosome-derived vacuoles that store and expel excess water. Selective elimination of Lyso-VRAC increases necrotic cell death under hypoosmotic, hypoxic, and hypothermic stress.\",\n      \"method\": \"Lysosome patch-clamp (whole-lysosome configuration), C-terminal targeting mutant (L706L707A), pharmacological tools, cell death assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct lysosomal electrophysiology plus specific targeting mutant that dissociates lysosomal from plasma membrane function, multiple stressors tested\",\n      \"pmids\": [\"33139539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Germ cell-specific disruption of Lrrc8a leads to abnormal sperm morphology (cytoplasm swelling, disorganized mitochondrial sheaths, angulated/coiled flagella) and male infertility in mice, consistent with impaired cell volume regulation in late spermatids. Sertoli cell-specific disruption does not cause infertility, indicating a cell-autonomous requirement in germ cells.\",\n      \"method\": \"Germ cell-specific and Sertoli cell-specific Lrrc8a KO mice, electron microscopy, sperm morphology analysis, fertility testing\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with negative control (Sertoli-specific KO), electron microscopy, replicated across two papers (PMID:29880644, 30135305)\",\n      \"pmids\": [\"29880644\", \"30135305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NHE1 polarizes to the cell leading edge and SWELL1 polarizes to the cell trailing edge during confined migration. SWELL1 polarization confers migration direction and efficiency. Optogenetic RhoA activation at the cell front triggers SWELL1 redistribution and migration direction reversal in SWELL1-expressing but not SWELL1-knockdown cells. Dual NHE1/SWELL1 knockdown inhibits breast cancer extravasation and metastasis in vivo.\",\n      \"method\": \"Live-cell imaging, optogenetics (RhoA activation), siRNA knockdown, in vivo extravasation/metastasis model, mathematical modeling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — optogenetic spatial control plus in vivo metastasis model, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"36253369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Endothelial LRRC8A (SWELL1) is required for VRAC in HUVECs and regulates AKT-eNOS signaling under basal, stretch, and shear-flow conditions. LRRC8A forms a GRB2-Cav1-eNOS signaling complex. Endothelium-restricted Lrrc8a KO mice develop hypertension upon chronic angiotensin-II infusion and exhibit impaired retinal blood flow in type 2 diabetes.\",\n      \"method\": \"Co-immunoprecipitation (GRB2-Cav1-eNOS complex with LRRC8A), endothelium-specific KO mice, patch-clamp, flow/stretch experiments, blood pressure telemetry, retinal angiography\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP signaling complex plus endothelium-specific KO with physiological readouts, single lab\",\n      \"pmids\": [\"33629656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SWELL1 (LRRC8A) encodes a swell-activated anion channel in skeletal muscle cells that regulates PI3K-AKT, ERK1/2, and mTOR signaling, muscle differentiation, myoblast fusion, oxygen consumption, and glycolysis. LRRC8A overexpression in KO myotubes rescues myotube formation by boosting PI3K-AKT-mTOR signaling. Skeletal muscle-targeted KO mice have smaller myofibers, reduced force, decreased exercise endurance, increased adiposity, and glucose intolerance on high-fat diet.\",\n      \"method\": \"Skeletal muscle-specific Lrrc8a KO mice, LRRC8A overexpression rescue, patch-clamp, AKT/ERK/mTOR phosphoblot, myoblast fusion assay, metabolic/exercise phenotyping\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific KO plus rescue overexpression with signaling and physiological readouts, single lab\",\n      \"pmids\": [\"32930093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"LRRC8/VRAC channels are permeable to glutathione (GSH) with a PGSH/PCl ratio of ~0.1 under hypotonic conditions. LRRC8A KO cells show no GSH conductance. LRRC8/VRAC-mediated GSH efflux modulates intracellular ROS levels and contributes to TGFβ1-induced epithelial-to-mesenchymal transition (EMT); pharmacological (DCPIB) or siRNA inhibition of LRRC8A attenuates EMT by preserving intracellular GSH and reducing ROS.\",\n      \"method\": \"LRRC8A KO cells, GSH current measurement, intracellular GSH quantification, DCPIB inhibition, siRNA, EMT marker expression\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO cells plus pharmacological inhibition with PGSH/PCl ratio measurement, single lab\",\n      \"pmids\": [\"31804464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LRRC8A downregulation in cisplatin-sensitive ovarian and alveolar carcinoma cells reduces p53 protein levels and downstream signaling (p21Waf1/Cip1, MDM2) and abolishes Caspase-9/-3 activation after cisplatin treatment. Cisplatin resistance correlates with reduced total LRRC8A expression (A2780) or reduced plasma membrane LRRC8A (A549). LRRC8A-dependent channel activity is upstream of cisplatin-induced apoptotic volume decrease.\",\n      \"method\": \"siRNA knockdown, pharmacological inhibition (NS3728, DIDS), immunoblot for p53/p21/MDM2/caspase activation, apoptosis assays\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA plus pharmacological inhibition with specific pathway readout, single lab\",\n      \"pmids\": [\"26984736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Cisplatin accumulation in cells correlates with LRRC8A protein expression and VSOAC channel activity; cellular platinum content is high when VSOAC is activated and reduced when LRRC8A is silenced or pharmacologically inhibited. This demonstrates that LRRC8A-containing channels mediate cisplatin uptake.\",\n      \"method\": \"siRNA knockdown, ICP-MS platinum quantification, pharmacological inhibition, VRAC activation/inhibition\",\n      \"journal\": \"Journal of inorganic biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct platinum quantification (ICP-MS) with genetic and pharmacological manipulation, single lab\",\n      \"pmids\": [\"27112899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"LRRC8/VRAC promotes mouse myoblast differentiation by facilitating plasma membrane hyperpolarization early during differentiation. LRRC8A knockdown or pharmacological VRAC inhibition reduces myogenin expression and suppresses myoblast fusion without affecting proliferation. VRAC acts upstream of K+ channel activation; inhibition prevents early hyperpolarization and the subsequent increase in intracellular steady-state Ca2+ levels during myogenesis.\",\n      \"method\": \"siRNA knockdown of LRRC8A, pharmacological VRAC inhibition, membrane potential measurement, Ca2+ imaging, myogenin immunostaining, myotube formation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockdown plus pharmacological inhibition with mechanistic epistasis (hyperpolarization upstream of K+ channels), single lab\",\n      \"pmids\": [\"31387946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In proximal tubules, LRRC8A and LRRC8D localize to basolateral membranes. Conditional deletion of LRRC8A in proximal (but not distal) tubules, and constitutive deletion of LRRC8D, cause proximal tubular injury, increased diuresis, and mild Fanconi-like symptoms. LRRC8C is exclusively found in vascular endothelium, and LRRC8E is specific for intercalated cells. These findings demonstrate that LRRC8A/D channels are required for basolateral exit of organic compounds in proximal tubules.\",\n      \"method\": \"Epitope-tagged LRRC8 knock-in mice (localization), conditional tubule-specific LRRC8A KO mice, constitutive LRRC8D KO, histology, urine/serum metabolomics\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific KO plus endogenous tagging for localization plus metabolomics, multiple genetic models\",\n      \"pmids\": [\"35777784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LRRC8A is an essential regulator of hypotonicity-induced NLRP3 inflammasome activation in murine macrophages, but is dispensable for canonical DAMP-induced NLRP3 activation. Chemical, biochemical, and genetic (KO) approaches demonstrated this selective requirement. Canonical DAMP-dependent NLRP3 activation remains sensitive to chloride channel inhibitors, indicating additional chloride-sensing mechanisms.\",\n      \"method\": \"LRRC8A KO macrophages, VRAC pharmacological inhibitors, NLRP3 inflammasome activation assay (IL-1β/IL-18 secretion), ASC speck formation\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus pharmacological confirmation with clear negative result for DAMP pathway, single lab\",\n      \"pmids\": [\"33216713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Phosphorylation of LRRC8A at Serine 174 (S174) acts as a checkpoint for VRAC activity in the steady state. ATP-evoked K+ efflux via P2X receptors alleviates S174 phosphorylation, thereby activating VRAC and potentiating cGAMP transport. Mutagenesis of S174 modulates the ATP responsiveness of LRRC8A channels.\",\n      \"method\": \"Site-directed mutagenesis (S174), P2X receptor agonist/antagonist, K+ efflux assays, cGAMP transport assay, VRAC electrophysiology\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis of specific phosphosite with functional assay, single lab\",\n      \"pmids\": [\"38847616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LRRC8A channel inhibition in macrophages promotes phagocytosis by activating AMPK, inducing nuclear translocation of Nrf2, and increasing CD36 transcription. Conditional KO of Lrrc8a in macrophages accelerates hematoma clearance, reduces neuronal death, and improves functional recovery after intracerebral hemorrhagic stroke.\",\n      \"method\": \"Macrophage/microglia-specific Lrrc8a KO mice, AMPK inhibitor, Nrf2 nuclear translocation assay, CD36 expression, ICH mouse model, VRAC pharmacological inhibition\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific KO plus pathway inhibitors with in vivo disease model, single lab\",\n      \"pmids\": [\"36465125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Brain-wide conditional deletion of LRRC8A causes fatal seizures in mice at 5–9 weeks of age. Hippocampal slice electrophysiology reveals increased pyramidal cell excitability and modified GABAergic inputs. LRRC8A-null hippocampi show decreased GLT-1, GAT-1, and glutamine synthetase protein levels, and reduced tissue glutamine, indicating that VRAC is required for normal astrocytic amino acid neurotransmitter homeostasis and brain excitability.\",\n      \"method\": \"NestinCre-driven brain-wide LRRC8A conditional KO, EEG/video seizure recording, brain slice patch-clamp, immunoblot, HPLC amino acid quantification\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — brain-specific KO with EEG confirmation, electrophysiology, and biochemical analysis, single lab\",\n      \"pmids\": [\"34469026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A truncated form of LRRC8A (deletion of LRR7–9 at C-terminus), caused by chromosomal translocation, acts as a dominant negative to inhibit B cell development when expressed in murine bone marrow transplantation experiments. LRRC8A is expressed on T cells and B-lineage cells and is required for normal B cell development.\",\n      \"method\": \"Chromosomal translocation analysis, cDNA cloning, murine bone marrow transplantation with truncated LRRC8A expression, flow cytometry\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo bone marrow reconstitution experiment with defined truncation construct, single lab\",\n      \"pmids\": [\"14660746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GlialCAM/MLC1 modulates LRRC8/VRAC currents indirectly: MLC1 cannot potentiate VRAC when LRRC8A is knocked down, but LRRC8A and MLC1 do not co-localize or co-immunoprecipitate and MLC1 does not potentiate LRRC8-mediated VRAC currents in Xenopus oocytes. Lack of MLC1 increases phosphorylation of LRRC8C (a VRAC subunit), and MLC1 overexpression reduces ERK phosphorylation, suggesting indirect modulation through signal transduction pathways.\",\n      \"method\": \"Co-immunoprecipitation (negative), Xenopus oocyte expression, LRRC8A siRNA knockdown, ERK phosphorylation immunoblot, LRRC8C phosphorylation assay\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis experiment plus negative co-IP plus phosphorylation assay, single lab; key result is that interaction is indirect\",\n      \"pmids\": [\"30076890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LRRC8A associates with MPRIP (myosin phosphatase rho-interacting protein), confirmed by LRRC8A immunoprecipitation/mass spectrometry, confocal co-localization, proximity ligation assay, and IP/western blot. LRRC8A-MPRIP interaction links LRRC8A to RhoA-MYPT1-actin pathway; siLRRC8A or VRAC blockade decreases RhoA activity in VSMCs, and MYPT1 phosphorylation is reduced in VSMC-specific Lrrc8a KO mesenteries, contributing to enhanced vascular relaxation.\",\n      \"method\": \"Co-IP/mass spectrometry, proximity ligation assay, confocal imaging, VSMC-specific Lrrc8a KO mice, RhoA activity assay, MYPT1 phospho-immunoblot\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP/MS plus PLA plus functional KO with pathway readout, single lab\",\n      \"pmids\": [\"37310356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"LRRC8A channel quantification in cells: approximately 10,000 VRAC channels per cell based on quantitative immunoblot with recombinant protein calibration. LRRC8A immunoprecipitation co-precipitates an excess of non-LRRC8A subunits, suggesting these subunits predominate numerically in heterohexamers.\",\n      \"method\": \"Quantitative immunoblot with recombinant protein calibration, co-immunoprecipitation of all five LRRC8 subunits from multiple tissues\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single co-IP method plus quantitative immunoblot; stoichiometry estimate is indirect\",\n      \"pmids\": [\"31771171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BioID proximity labeling of LRRC8A identifies interactions with cell-cell junction proteins, calcium homeostasis regulators, kinases, and GTPase signaling components. Re-evaluation of LRRC8A in HCT116 LRRC8A-KO cells confirms no effect on cell proliferation or migration, consistent with PMID:31151189.\",\n      \"method\": \"BioID proximity-dependent biotinylation and mass spectrometry, LRRC8A-KO proliferation/migration assay\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — proximity labeling identifies candidate interactors but does not validate direct binding; single lab, single method for interactome\",\n      \"pmids\": [\"38909013\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LRRC8A (SWELL1) is the obligatory subunit of the volume-regulated anion channel (VRAC), forming heterohexameric complexes (~800 kDa) with LRRC8B-E paralogues whose subunit composition determines anion/osmolyte selectivity, inactivation kinetics, and oxidant sensitivity; the hexameric structure, solved by cryo-EM and X-ray crystallography, reveals a connexin-like transmembrane pore with a cytoplasmic LRR domain that couples volume/ionic-strength sensing to gating, the N-termini fold into the pore forming a second selectivity filter, and DCPIB plugs the extracellular filter; beyond volume regulation, LRRC8A channels transport cGAMP, glutathione, glutamate, and cisplatin, signal through GRB2-PI3K-AKT and JAK2-STAT3 scaffolds via its C-terminal LRR domain, interact with Nox1/MPRIP complexes to regulate ROS and vascular tone, are activated by p38-MSK1 phosphorylation at S174/S217 during hypertonic stress, and localize to both the plasma membrane and lysosomes (directed by a C-terminal LL motif) where lysosomal VRAC supports osmotic homeostasis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"LRRC8A (SWELL1) is the obligatory, pore-forming subunit of the volume-regulated anion channel (VRAC), a heterohexameric complex it forms with LRRC8B–E paralogues that mediates regulatory volume decrease and the swelling-activated efflux of anions and organic osmolytes [#0, #1]. Genetic ablation eliminates VRAC currents, and reconstitution of LRRC8 complexes into lipid bilayers is sufficient to generate anion channels activated by osmolality gradients or by reduced cytoplasmic ionic strength [#1]. Structural studies establish a connexin-like hexameric transmembrane pore constricted on the extracellular side by a selectivity filter, with a cytoplasmic leucine-rich repeat (LRR) domain that undergoes rigid-body dilation coupled to pore opening; the N-termini fold back into the pore to form a second selectivity filter, the inhibitor DCPIB plugs the extracellular filter, and subunit composition (e.g. the 4A:2C heterohexamer) tunes gating and activation [#2, #4, #7, #8]. Pore architecture is governed by the N-terminus, the TM2–TM3 intracellular loop, and residues such as E6, which control conductance, anion selectivity, and inactivation [#5, #6]. Subunit composition further determines substrate selectivity and oxidant sensitivity: distinct heteromers preferentially conduct charged versus uncharged osmolytes and are oppositely modulated by cysteine oxidation [#20, #21]. Channel activity is regulated by stress-kinase phosphorylation, with MSK1 acting at S217 to drive regulatory volume increase via the WNK–NKCC pathway and S174 phosphorylation serving as a steady-state checkpoint relieved by P2X-mediated K+ efflux [#16, #33]. Beyond volume regulation, LRRC8A channels transport diverse cargo — glutamate and excitatory amino acids in astrocytes, glutathione, cisplatin, and the immune second messenger cGAMP — linking VRAC to neurotransmission, redox balance, chemosensitivity, and STING-dependent interferon responses [#9, #12, #13, #14, #27, #29]. Through its C-terminal LRR domain, LRRC8A additionally scaffolds signaling: it binds GRB2 (with Cav1/eNOS) to govern insulin–PI3K–AKT and AKT–eNOS signaling, engages GRB2–JAK2–STAT3 in cardiac fibrosis, associates with Nox1/Nox2/Nox4–p22phox complexes to control ROS production, and binds MPRIP to modulate RhoA–MYPT1 signaling and vascular tone [#11, #17, #18, #19, #25, #38]. Tissue-specific deletions reveal physiological roles in adipocyte and β-cell glucose/insulin handling, skeletal muscle differentiation, spermatogenesis, proximal-tubule organic-compound transport, lysosomal osmotic homeostasis, and astrocytic neurotransmitter homeostasis, where brain-wide loss causes fatal seizures [#11, #14, #15, #22, #23, #26, #31, #35].\",\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified the long-sought molecular identity of VRAC, establishing LRRC8A as the essential pore-forming subunit whose loss abolishes swelling-activated anion currents.\",\n      \"evidence\": \"Two independent genome-wide siRNA screens with CRISPR genomic disruption, patch-clamp, and point mutagenesis altering anion selectivity\",\n      \"pmids\": [\"24790029\", \"24725410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Subunit stoichiometry and atomic architecture not yet defined\", \"Mechanism coupling volume sensing to gating unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended VRAC function beyond chloride to organic osmolyte and excitatory amino acid release, showing LRRC8A is required for both swelling- and receptor-triggered efflux.\",\n      \"evidence\": \"siRNA knockdown with radiotracer efflux assays in rat astrocytes\",\n      \"pmids\": [\"25172945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Subunit composition determining osmolyte selectivity not defined here\", \"Direct versus indirect permeation not distinguished\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealed a non-channel signaling role, with LRRC8A scaffolding GRB2/GAB2/LCK to drive AKT activation and thymocyte development.\",\n      \"evidence\": \"Co-immunoprecipitation, Lrrc8a-/- phenotyping, bone marrow chimeras, phospho-AKT immunoblot\",\n      \"pmids\": [\"24752297\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Relationship between channel activity and scaffolding function unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated that LRRC8 complexes are themselves the channel by reconstituting ~800 kDa heteromers into bilayers and showing low ionic strength activates them, defining the physical activating stimulus.\",\n      \"evidence\": \"Lipid bilayer reconstitution, single-channel electrophysiology, size-exclusion chromatography\",\n      \"pmids\": [\"26824658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure still absent\", \"Physiological link between ionic strength sensing and cell volume not fully resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Linked LRRC8A to platinum drug handling and apoptosis, showing it mediates cisplatin uptake and is required for cisplatin-induced p53 and caspase activation.\",\n      \"evidence\": \"siRNA knockdown, ICP-MS platinum quantification, pharmacological inhibition, apoptosis assays\",\n      \"pmids\": [\"27112899\", \"26984736\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab studies\", \"Direct cisplatin permeation through the pore not structurally demonstrated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected LRRC8A to redox and inflammatory signaling via physical association with Nox1/p22phox required for TNFα-induced superoxide and NF-κB activation.\",\n      \"evidence\": \"Co-IP, co-localization, siRNA, superoxide assays, NF-κB reporter in vascular smooth muscle cells\",\n      \"pmids\": [\"27838438\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Whether interaction depends on channel conductance unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established that subunit composition governs both substrate selectivity and oxidant sensitivity, explaining functional heterogeneity of VRACs within a single cell.\",\n      \"evidence\": \"Subunit-specific RNAi with radiotracer efflux; defined heteromer constructs with oxidant application and patch-clamp\",\n      \"pmids\": [\"28833202\", \"28841766\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab for each\", \"Molecular basis of subunit-specific selectivity not structurally defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined a metabolic signaling role, with the C-terminal LRR domain binding GRB2/Cav1 to control adipocyte insulin–PI3K–AKT2–GLUT4 signaling and systemic glycemia.\",\n      \"evidence\": \"Reciprocal co-IP with domain mutants, adipose-specific KO mice, glucose uptake and rescue assays\",\n      \"pmids\": [\"28436964\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether scaffolding requires channel activity not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Solved the hexameric, connexin-like channel architecture with an extracellular selectivity filter and cytoplasmic LRR arc adopting compact/relaxed conformations implicated in gating.\",\n      \"evidence\": \"Cryo-EM and X-ray crystallography of homomeric LRRC8A from independent labs\",\n      \"pmids\": [\"29769723\", \"30127360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Open/conductive state not captured\", \"Heteromeric assembly architecture unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Mapped functional pore determinants to the N-terminus and the TM2–TM3 intracellular loop, identifying residues controlling conductance, selectivity, and inactivation.\",\n      \"evidence\": \"Chimeric and SCAM mutagenesis with patch-clamp and MTSES modification in LRRC8-null cells\",\n      \"pmids\": [\"29853476\", \"29925591\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural visualization of N-termini in the pore not yet achieved here\", \"How loops couple to LRR-driven gating unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated a cell-autonomous physiological requirement in germ cells, where Lrrc8a loss causes spermatid volume dysregulation and male infertility.\",\n      \"evidence\": \"Germ cell- and Sertoli cell-specific KO mice with electron microscopy and fertility testing\",\n      \"pmids\": [\"29880644\", \"30135305\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Subunit partners in germ cells not defined\", \"Molecular cargo relevant to spermatid volume not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Clarified GlialCAM/MLC1 modulation of VRAC as indirect via signaling rather than direct binding, refining the interactome.\",\n      \"evidence\": \"Negative co-IP, Xenopus oocyte expression, LRRC8A knockdown, ERK and LRRC8C phosphorylation assays\",\n      \"pmids\": [\"30076890\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the signaling intermediary unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Captured an inhibitor-bound structure showing DCPIB plugs the extracellular filter and revealed lipid-dependent coupled dilation of LRRs and pore as a gating mechanism.\",\n      \"evidence\": \"Cryo-EM in lipid nanodiscs with DCPIB, constricted and expanded states\",\n      \"pmids\": [\"30775971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Fully open conductive state not resolved\", \"Direct link between LRR dilation and ionic-strength sensing not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established astrocytic VRAC as a mediator of non-vesicular glutamate release shaping synaptic transmission, memory, and ischemic injury.\",\n      \"evidence\": \"Astrocyte-specific Swell1 KO mice, patch-clamp, glutamate release assays, behavior, MCAO stroke model\",\n      \"pmids\": [\"30982627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Subunit composition of astrocytic channel not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed VRAC conducts glutathione, linking channel activity to intracellular ROS and TGFβ1-driven EMT.\",\n      \"evidence\": \"LRRC8A KO cells, GSH current and PGSH/PCl measurement, DCPIB and siRNA, EMT markers\",\n      \"pmids\": [\"31804464\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Subunit determinants of GSH permeation not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a role in myoblast differentiation through VRAC-driven membrane hyperpolarization upstream of K+ channels and Ca2+ signaling.\",\n      \"evidence\": \"siRNA, pharmacological VRAC inhibition, membrane potential and Ca2+ imaging, myogenin and fusion assays\",\n      \"pmids\": [\"31387946\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Molecular mechanism connecting anion flux to hyperpolarization unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified LRRC8A channels as transporters of the immune second messenger cGAMP across plasma membranes, enabling cell-to-cell STING-dependent interferon signaling and antiviral immunity.\",\n      \"evidence\": \"Transport assays, electrophysiology, LRRC8A and Lrrc8e KO/mice, CRISPR screen, STING reporters, HSV-1 challenge\",\n      \"pmids\": [\"32277911\", \"33171122\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Directionality determinants in vivo incompletely defined\", \"Role of LRRC8D inhibition mechanistically unexplained\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed a distinct lysosomal VRAC directed by a C-terminal di-leucine motif that supports osmotic homeostasis and protects against necrotic death under stress.\",\n      \"evidence\": \"Whole-lysosome patch-clamp, L706L707A targeting mutant dissociating lysosomal from plasma-membrane function, cell death assays\",\n      \"pmids\": [\"33139539\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Lysosomal subunit composition not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed LRRC8A selectively required for hypotonicity-induced but not canonical DAMP-driven NLRP3 inflammasome activation, indicating additional chloride-sensing mechanisms.\",\n      \"evidence\": \"LRRC8A KO macrophages, VRAC inhibitors, IL-1β/IL-18 and ASC speck assays\",\n      \"pmids\": [\"33216713\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of redundant chloride sensors unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established a skeletal muscle role coupling VRAC to PI3K–AKT–mTOR signaling, differentiation, metabolism, and exercise capacity.\",\n      \"evidence\": \"Muscle-specific KO mice, overexpression rescue, patch-clamp, signaling immunoblots, metabolic phenotyping\",\n      \"pmids\": [\"32930093\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Whether metabolic effect requires anion conduction or scaffolding unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined stress-kinase regulation, with p38–MSK1 phosphorylation at S217 activating VRAC to drive WNK–NKCC-dependent regulatory volume increase and survival.\",\n      \"evidence\": \"Genome-wide CRISPR survival screen, S217A mutagenesis, kinase assays, RVI and NKCC inhibition\",\n      \"pmids\": [\"34083438\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural consequence of S217 phosphorylation not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended LRR-domain scaffolding to Nox2/Nox4–p22phox and GRB2–JAK2–STAT3 axes driving AngII cardiac hypertrophy and post-MI fibrosis.\",\n      \"evidence\": \"Co-IP with LRRD domain mutants, myofibroblast-specific KO, in vivo knockdown, ROS and phospho-signaling assays\",\n      \"pmids\": [\"33515753\", \"35966575\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab per study\", \"Channel-independence of these signaling roles not formally shown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined endothelial LRRC8A in a GRB2–Cav1–eNOS complex regulating AKT–eNOS signaling, blood pressure, and diabetic retinal perfusion.\",\n      \"evidence\": \"Co-IP, endothelium-specific KO mice, patch-clamp, flow/stretch, blood pressure telemetry, retinal angiography\",\n      \"pmids\": [\"33629656\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Mechanical activation mechanism not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed brain-wide VRAC is essential for astrocytic neurotransmitter homeostasis, with loss causing fatal seizures and dysregulated glutamate/GABA handling.\",\n      \"evidence\": \"NestinCre brain-wide KO, EEG/video, slice patch-clamp, immunoblot, HPLC amino acid quantification\",\n      \"pmids\": [\"34469026\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Whether seizures arise from osmolyte transport or transporter expression changes not disentangled\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolved heterohexameric LRRC8A:C architecture (4A:2C), showing flexible LRRC8C subunits destabilize closed-state A subunits to enhance activation and that pore lipids block conduction when closed.\",\n      \"evidence\": \"Cryo-EM with fiducial-tagged subunit identification and functional electrophysiology\",\n      \"pmids\": [\"36928458\", \"36522427\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures of other heteromer compositions absent\", \"Open-state structure of heteromer not captured\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Implicated LRRC8A in directional confined migration, with RhoA-dependent trailing-edge polarization and a role in breast cancer extravasation and metastasis.\",\n      \"evidence\": \"Live-cell imaging, optogenetic RhoA activation, siRNA, in vivo metastasis model, modeling\",\n      \"pmids\": [\"36253369\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Molecular link between RhoA and SWELL1 redistribution unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined a renal physiological role, localizing LRRC8A/D to proximal tubule basolateral membranes required for organic compound exit, with loss causing Fanconi-like injury.\",\n      \"evidence\": \"Epitope-tagged knock-in localization, tubule-specific KO and constitutive LRRC8D KO, histology, urine/serum metabolomics\",\n      \"pmids\": [\"35777784\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific transported metabolites incompletely catalogued\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Resolved the channel N-termini folding into the pore as a second selectivity filter, with ionic-strength-dependent NT mobility providing a structural basis for activation.\",\n      \"evidence\": \"2.8-Å cryo-EM and molecular dynamics simulations\",\n      \"pmids\": [\"37543949\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Experimental validation of MD-predicted NT motions limited\", \"Coupling between NT mobility and LRR dilation not fully integrated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified MPRIP as an LRRC8A partner linking the channel to RhoA–MYPT1–actin signaling and vascular relaxation.\",\n      \"evidence\": \"Co-IP/mass spectrometry, proximity ligation assay, confocal imaging, VSMC-specific KO, RhoA and MYPT1 assays\",\n      \"pmids\": [\"37310356\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct versus complex-mediated binding not fully resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed LRRC8A inhibition in macrophages promotes phagocytosis via AMPK–Nrf2–CD36, improving outcomes after hemorrhagic stroke.\",\n      \"evidence\": \"Macrophage/microglia-specific KO, AMPK inhibitor, Nrf2 translocation, CD36 expression, ICH model\",\n      \"pmids\": [\"36465125\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Mechanism connecting channel activity to AMPK unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined S174 phosphorylation as a steady-state checkpoint for VRAC, relieved by P2X-mediated K+ efflux to potentiate cGAMP transport.\",\n      \"evidence\": \"S174 mutagenesis, P2X agonist/antagonist, K+ efflux and cGAMP transport assays, electrophysiology\",\n      \"pmids\": [\"38847616\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase/phosphatase acting on S174 not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How LRRC8A's channel conduction is mechanistically separable from its C-terminal LRR scaffolding functions, and what defines the open-state structure of native heteromeric channels, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No open conductive-state structure of a physiological heteromer\", \"Channel-dependent versus -independent contributions to AKT/JAK2/Nox/RhoA signaling not cleanly dissected\", \"In vivo subunit composition across tissues incompletely mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 9, 12, 13, 27, 29, 31]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [11, 19, 25]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [2, 3, 5]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [16, 33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 12, 22, 25, 31]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 1, 12, 13, 27, 29, 31]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [16, 22, 33]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 12, 13, 32, 34, 36]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 19, 25, 38]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [9, 14, 35]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [23, 26, 30]}\n    ],\n    \"complexes\": [\"VRAC (volume-regulated anion channel, LRRC8 heterohexamer)\"],\n    \"partners\": [\"LRRC8C\", \"LRRC8D\", \"LRRC8E\", \"GRB2\", \"CAV1\", \"MPRIP\", \"NOX1\", \"EEF1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}